<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Combination of tocolytic agents for inhibiting preterm labour - Vogel, JP - 2014 | Cochrane Library</title> <meta content="Combination of tocolytic agents for inhibiting preterm labour - Vogel, JP - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006169.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Combination of tocolytic agents for inhibiting preterm labour - Vogel, JP - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006169.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006169.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Combination of tocolytic agents for inhibiting preterm labour" name="citation_title"/> <meta content="Joshua P Vogel" name="citation_author"/> <meta content="World Health Organization" name="citation_author_institution"/> <meta content="vogeljo@who.int" name="citation_author_email"/> <meta content="Juan Manuel Nardin" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="Therese Dowswell" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="Helen M West" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="Olufemi T Oladapo" name="citation_author"/> <meta content="World Health Organization" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD006169.pub2" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/07/11" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006169.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006169.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006169.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Drug Therapy, Combination; Obstetric Labor, Premature [*drug therapy]; Premature Birth [*drug therapy]; Randomized Controlled Trials as Topic; Tocolysis [*methods]; Tocolytic Agents [*therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006169.pub2&amp;doi=10.1002/14651858.CD006169.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="QzbxnhyM";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006169\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006169\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006169\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006169\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","hr","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006169.pub2",title:"Combination of tocolytic agents for inhibiting preterm labour",firstPublishedDate:"Jul 11, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=QzbxnhyM&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006169.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006169.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006169.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006169.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006169.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006169.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006169.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006169.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006169.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006169.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4784 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006169.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/full#CD006169-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/full#CD006169-sec-0109"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/full#CD006169-sec-0022"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/full#CD006169-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/full#CD006169-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/full#CD006169-sec-0072"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/full#CD006169-sec-0103"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/table_n/CD006169StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/table_n/CD006169StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Combination of tocolytic agents for inhibiting preterm labour</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/information#CD006169-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Joshua P Vogel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/information#CD006169-cr-0003">Juan Manuel Nardin</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/information#CD006169-cr-0004">Therese Dowswell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/information#CD006169-cr-0005">Helen M West</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006169.pub2/information#CD006169-cr-0006">Olufemi T Oladapo</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/information/en#CD006169-sec-0116">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 11 July 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006169.pub2">https://doi.org/10.1002/14651858.CD006169.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006169-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006169-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006169-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006169-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006169-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006169-abs-0001" lang="en"> <section id="CD006169-sec-0001"> <h3 class="title" id="CD006169-sec-0001">Background</h3> <p>Preterm birth represents the single largest cause of mortality and morbidity for newborns and a major cause of morbidity for pregnant women. Tocolytic agents include a wide range of drugs that can inhibit labour to prolong pregnancy. This may gain time to allow the fetus to mature further before being born, permit antenatal corticosteroid administration for lung maturation, and allow time for intra‐uterine transfer to a hospital with neonatal intensive care facilities. However, some tocolytic drugs are associated with severe side effects. Combinations of tocolytic drugs may be more effective over single tocolytic agents or no intervention, without adversely affecting the mother or neonate. </p> </section> <section id="CD006169-sec-0002"> <h3 class="title" id="CD006169-sec-0002">Objectives</h3> <p>To assess the effects on maternal, fetal and neonatal outcomes of any combination of tocolytic drugs for the treatment of preterm labour when compared with any other treatment, no treatment or placebo. </p> </section> <section id="CD006169-sec-0003"> <h3 class="title" id="CD006169-sec-0003">Search methods</h3> <p>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 January 2014) and reference lists of retrieved studies. </p> </section> <section id="CD006169-sec-0004"> <h3 class="title" id="CD006169-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials comparing a combination of tocolytic agents, administered by any route or any dose, for inhibiting preterm labour versus any other treatment (including other combinations of tocolytics or single tocolytics), no intervention or placebo. </p> </section> <section id="CD006169-sec-0005"> <h3 class="title" id="CD006169-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed study reports for eligibility, carried out data extraction and assessed risk of bias. </p> </section> <section id="CD006169-sec-0006"> <h3 class="title" id="CD006169-sec-0006">Main results</h3> <p>Eleven studies met our inclusion criteria. Two studies did not report any outcome data relevant to the review, so the results of the review are based on nine trials that contributed data. Primary outcomes were perinatal mortality, serious maternal or infant outcomes, adverse drug reactions, birth before 48 hours of trial entry, birth before 34 weeks' gestation and preterm neonates delivered without a full course of antenatal steroids completed 24 hours before birth. The quality of evidence in included trials was mixed; only three of the trials were placebo controlled. </p> <p>The included trials examined seven different comparisons: intravenous (IV) ritodrine plus oral or IV magnesium (sulphate or gluconate) versus IV ritodrine alone (three trials, 231 women); IV ritodrine plus indomethacin suppositories versus IV ritodrine alone (one trial, 208 women); IV ritodrine plus vaginal progesterone versus IV ritodrine alone (one trial, 83 women); IV hexoprenaline sulphate plus IV magnesium hydrochloride versus IV hexoprenaline sulphate alone (one trial, 24 women); IV fenoterol plus oral naproxen versus IV fenoterol alone (one trial, 72 women); oral pentoxifylline plus IV magnesium sulphate plus IV fenoterol versus IV magnesium sulphate plus IV fenoterol (one trial, 125 women); and, IV terbutaline plus oral metoprolol versus IV terbutaline alone (one trial, 17 women). Few studies with small numbers of women were available for each comparison, hence very little data were pooled in meta‐analysis. In all trials, not many of the primary outcomes were reported. </p> <p>Three trials examined intravenous (IV) ritodrine plus IV or oral magnesium (sulphate or gluconate) compared with IV ritodrine alone. One study, with 41 women, reported more adverse drug reactions in the group receiving the combined tocolytics (risk ratio (RR) 7.79, 95% confidence interval (CI) 1.11 to 54.80). Two trials reported discontinuation of therapy due to severe side effects (results were not combined due to high statistical heterogeneity, I² = 83%); one trial reported increased severe side effects in the group receiving IV ritodrine alone (RR 7.79, 95% CI 1.11 to 54.80, 41 women); in the other trial there was no clear difference between groups (RR 0.23, 95% CI 0.03 to 1.97, 107 women). Other primary outcomes were not reported. </p> <p>One trial assessed IV ritodrine plus indomethacin suppositories versus IV ritodrine alone. There were no significant differences between groups for perinatal mortality or serious neonatal morbidity. Results for other primary outcomes were not reported. </p> <p>There were no significant differences between groups receiving IV ritodrine plus vaginal progesterone compared with IV ritodrine alone for most outcomes reported, although the latency period (time from recruitment to delivery) was increased in the group receiving the combination of tocolytics. </p> <p>For other combinations of tocolytic agents, primary outcomes were rarely reported and for secondary outcomes results did not demonstrate differences between groups. </p> </section> <section id="CD006169-sec-0007"> <h3 class="title" id="CD006169-sec-0007">Authors' conclusions</h3> <p>It is unclear whether a combination of tocolytic drugs for preterm labour is more advantageous for women and/or newborns due to a lack of large, well‐designed trials including the outcomes of interest. There are no trials of combination regimens using widely used tocolytic agents, such as calcium channel blockers (nifedipine) and/or oxytocin receptor antagonists (atosiban). Further trials are needed before specific conclusions on use of combination tocolytic therapy for preterm labour can be made. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006169-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006169-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006169-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006169-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006169-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD006169-abs-0005">Hrvatski</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006169-abs-0004" lang="en"> <h3>Combinations of tocolytic drugs for inhibiting preterm labour</h3> <p>Preterm birth (birth before 37 weeks) is the single largest cause of deaths and ill health for newborn babies and a major cause of complications for pregnant women. Tocolytic agents include a wide range of drugs that can slow or stop labour contractions so as to prolong pregnancy and potentially improve the health outcomes for the baby. Using a combination of two or more tocolytic drugs may improve the length of time the pregnancy is prolonged over using a single tocolytic drug or no intervention, without adversely affecting the mother or baby or worsening drug side effects. </p> <p>This review examined the effects of any combination of tocolytic drugs for the treatment of preterm labour, compared with any other treatment, no treatment or placebo. The results of the review are based on data from nine randomised controlled trials that examined seven different drug comparisons. </p> <p>Three trials examined the betamimetic drug ritodrine plus magnesium compared with ritodrine alone. The trials reported on adverse side effects, with inconsistency between the trials as to which treatment gave fewer severe side effects. Other outcomes were either not reported or not clearly different between treatment groups. </p> <p>One trial looked at ritodrine plus indomethacin versus ritodrine alone. There were no clear differences between groups for serious newborn ill health. Results for other outcomes were not clearly different. There were no clear differences between groups receiving ritodrine plus progesterone compared with ritodrine alone for most outcomes reported, although the time between giving the drugs and the birth was increased in the group receiving the combination of tocolytics. For other combinations of tocolytic agents, results did not demonstrate differences between groups. There were no trials of combination regimens using widely used tocolytic agents, such as calcium channel blockers (nifedipine) and oxytocin receptor antagonists (atosiban). </p> <p>Due to insufficient evidence, it is unclear if combination tocolytic regimens are more or less effective than using a single tocolytic drug, or if they have more adverse effects. Some widely used tocolytic drugs have not been examined in trials as part of combination regimens, so further research is needed. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006169-sec-0109" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006169-sec-0109"></div> <h3 class="title" id="CD006169-sec-0110">Implications for practice</h3> <section id="CD006169-sec-0110"> <p>It remains unclear whether using a combination of tocolytic drugs for inhibiting preterm labour is more advantageous for women and/or newborns given the lack of studies. There is no direct trial evidence to demonstrate that combination tocolytic therapies are equivalent or superior (in either efficacy or side‐effect profile) to commonly used single tocolytic agents, such as calcium channel blockers or oxytocin receptor antagonists. Further trials are needed before specific conclusions on use of combination tocolytic therapy for preterm labour can be made. </p> </section> <h3 class="title" id="CD006169-sec-0111">Implications for research</h3> <section id="CD006169-sec-0111"> <p>Additional studies are urgently needed to explore the relationships between combinations of tocolytics versus any other treatment for preterm labour. These studies should prioritise (where appropriate) the inclusion of commonly used tocolytic agents, such as calcium channel blockers and/or oxytocin antagonists. Reporting of a range of maternal and newborn mortality and morbidity outcomes, as well as reporting the use of antenatal corticosteroids, is needed in order to obtain meaningful data for clinical decision‐making. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006169-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006169-sec-0022"></div> <section id="CD006169-sec-0023"> <h3 class="title" id="CD006169-sec-0023">Description of the condition</h3> <p>Preterm birth is defined as birth before 37 completed weeks of gestation (<a href="./references#CD006169-bbs2-0032" title="BryceJ , Boschi‐PintoC , ShibuyaK , BlackRE , for the WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children. Lancet2005;365(9465):1147‐52. ">Bryce 2005</a>). It occurs in 11.1% of births globally, affecting an estimated 14.9 million babies every year (<a href="./references#CD006169-bbs2-0029" title="BlencoweH , CousensS , OestergaardMZ , ChouD , MollerAB , NarwalR , et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since1990 for selected countries: a systematic analysis and implications. Lancet2012;9(379):2162‐72. ">Blencowe 2012</a>; <a href="./references#CD006169-bbs2-0030" title="March ofDimes , PMNCH , Save theChildren , WHO . Born Too Soon Report: The Global Action Report on Preterm Birth. Geneva, Switzerland: World Health Organization, 2012. ">Born Too Soon Report 2012</a>). In an analysis of 65 countries with reliable trend data on preterm births (1990 to 2010), 62 countries had stable or rising preterm birth rates (<a href="./references#CD006169-bbs2-0029" title="BlencoweH , CousensS , OestergaardMZ , ChouD , MollerAB , NarwalR , et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since1990 for selected countries: a systematic analysis and implications. Lancet2012;9(379):2162‐72. ">Blencowe 2012</a>). This has been attributed at least in part to rising rates of provider‐initiated preterm birth and improved registration of extremely preterm births (<a href="./references#CD006169-bbs2-0029" title="BlencoweH , CousensS , OestergaardMZ , ChouD , MollerAB , NarwalR , et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since1990 for selected countries: a systematic analysis and implications. Lancet2012;9(379):2162‐72. ">Blencowe 2012</a>; <a href="./references#CD006169-bbs2-0035" title="DavidoffMJ , DiasT , DamusK , RussellR , BettegowdaVR , DolanS , et al. Changes in the gestational age distribution among U.S. singleton births: impact on rates of late preterm birth, 1992 to 2002. Seminars in Perinatology2006;30(5):313. ">Davidoff 2006</a>). It is generally accepted that approximately 30% to 35% of preterm births are provider‐initiated (by induction or caesarean section) for maternal and/or fetal indications, while 65% to 70% are spontaneous preterm births. Spontaneous preterm births includes those due to spontaneous preterm labour (40% to 45%) and those following preterm rupture of membranes (25% to 30%) (<a href="./references#CD006169-bbs2-0041" title="GoldenbergRL , CulhaneJF , IamsJD , RomeroR . Epidemiology and causes of preterm birth. Lancet2008;371(9606):75‐84. ">Goldenberg 2008</a>). The precise cause of spontaneous preterm birth is often unknown, however several maternal factors are known to increase risk, including maternal age (adolescence and advanced age), maternal history of preterm birth, race, multiple pregnancy, short inter‐pregnancy interval, infections, medical conditions, poor nutrition, lifestyle factors, psychological factors and genetic predisposition (<a href="./references#CD006169-bbs2-0041" title="GoldenbergRL , CulhaneJF , IamsJD , RomeroR . Epidemiology and causes of preterm birth. Lancet2008;371(9606):75‐84. ">Goldenberg 2008</a>; <a href="./references#CD006169-bbs2-0051" title="PlunkettJ , MugliaLJ . Genetic contributions to preterm birth: implications from epidemiological and genetic association studies. Annals of Medicine2008;40:167‐95. ">Plunkett 2008</a>). </p> <p>Preterm birth is the single largest cause of newborn mortality and is estimated to account for 29% of deaths in the first four weeks of life (<a href="./references#CD006169-bbs2-0047" title="LawnJE , KerberK , Enweronu‐LaryeaC , CousensS . 3.6 million neonatal deaths—what is progressing and what is not?. Seminars in Perinatology2010;34(6):371‐86. ">Lawn 2009</a>). Preterm newborns have higher rates of a range of neonatal morbidities, including respiratory (respiratory distress syndrome, persistent pulmonary hypertension) infectious (pneumonia, meningitis, sepsis, necrotizing enterocolitis), central nervous system (intraventricular haemorrhage, seizures) and metabolic (hypoglycaemia, jaundice and hyperbilirubinaemia) morbidities (<a href="./references#CD006169-bbs2-0055" title="TeuneMJ , BakhuizenS , Gyamfi BannermanC , OpmeerBC , vanKaamAH , vanWassenaerAG , et al. A systematic review of severe morbidity in infants born late preterm. American Journal of Obstetrics and Gynecology2011;205(4):374.e1‐374.e9. ">Teune 2011</a>). Administering antenatal corticosteroids to women at risk of preterm birth has been shown to reduce the overall risk of neonatal death, respiratory distress syndrome, cerebroventricular haemorrhage, necrotising enterocolitis, the need for respiratory support or intensive care admissions and systemic infections in the first 48 hours of life (<a href="./references#CD006169-bbs2-0053" title="RobertsD , DalzielSR . Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD004454.pub2] ">Roberts 2006</a>). </p> <p>In the post‐neonatal period, preterm infants are at continued risk of mortality and morbidity (<a href="./references#CD006169-bbs2-0045" title="KatzJ , LeeAC , KozukiN , LawnJE , CousensS , BlencoweH , et al. Mortality risk in preterm and small‐for‐gestational‐age infants in low‐income and middle‐income countries: a pooled country analysis. Lancet2013;382(9890):417‐25. ">Katz 2013</a>; <a href="./references#CD006169-bbs2-0055" title="TeuneMJ , BakhuizenS , Gyamfi BannermanC , OpmeerBC , vanKaamAH , vanWassenaerAG , et al. A systematic review of severe morbidity in infants born late preterm. American Journal of Obstetrics and Gynecology2011;205(4):374.e1‐374.e9. ">Teune 2011</a>). In the longer term, they experience more illnesses, hospital admissions and educational and behavioral problems in childhood and early adulthood, (<a href="./references#CD006169-bbs2-0031" title="BoyleEM , PoulsenG , FieldDJ , KurinczukJJ , WolkeD , AlfirevicZ , et al. Effects of gestational age at birth on health outcomes at 3 and 5 years of age: population based cohort study. BMJ2011;344:e896. ">Boyle 2011</a>; <a href="./references#CD006169-bbs2-0037" title="EkeusC , LindströmK , LindbladF , RasmussenF , HjernA . Preterm birth, social disadvantage, and cognitive competence in Swedish 18‐ to 19‐year‐old men. Paediatrics2010;125:e67‐e73. ">Ekeus 2010</a>; <a href="./references#CD006169-bbs2-0054" title="TalgeN , HolzmanC , WangJ , LuciaV . Late‐preterm birth and its association with cognitive and socioemotional outcomes at 6 years of age. Pediatrics2010;126(6):1124‐31. ">Talge 2010</a>; <a href="./references#CD006169-bbs2-0056" title="vanBaarALA , VermaasJJ , KnotsEE , deKleineMJKM , SoonsPP . Functioning at school age of moderately preterm children born at 32 to 36 weeks' gestational age. Paediatrics2009;124(1):251‐7. ">van Baar 2009</a>) as well as higher rates of visual and hearing impairments, cerebral palsy and neuro‐developmental and behavioural impairments (<a href="./references#CD006169-bbs2-0043" title="HagbergB , HagbergG , BeckungE , UvebrantP . Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year period 1991‐94. Acta Paediatrica2001;90(3):271‐7. ">Hagberg 2001</a>; <a href="./references#CD006169-bbs2-0048" title="MarlowN , WolkeD , BracewellMA , SamaraM , EPICure Study Group. Neurologic and developmental disability at six years of age after extremely preterm birth. New England Journal of Medicine2005;352(1):9‐19. ">Marlow 2005</a>; <a href="./references#CD006169-bbs2-0050" title="O'ConnorAR , WilsonCM , FielderAR . Ophthalmological problems associated with preterm birth. Eye (London)2007;21(10):1254‐60. ">O'Connor 2007</a>). </p> </section> <section id="CD006169-sec-0024"> <h3 class="title" id="CD006169-sec-0024">Description of the intervention</h3> <section id="CD006169-sec-0025"> <h4 class="title">Tocolytic therapy</h4> <p>Tocolytic agents include a wide range of drugs that can slow or suppress uterine contractions. Tocolytics are considered advantageous in spontaneous preterm labour to (a) allow time for the fetus to mature, potentially avoiding the deleterious effects of prematurity; (b) allow time for antenatal corticosteroids (ACS) to be administered and have a clinical effect; and (c) allow time for intrauterine transfer to a higher‐care centre, where neonatal intensive care facilities (or other services) are available (<a href="./references#CD006169-bbs2-0028" title="AnotayanonthS , SubhedarNV , NeilsonJP , HarigopalS . Betamimetics for inhibiting preterm labour. Cochrane Database of Systematic Reviews2004, Issue 4. [DOI: 10.1002/14651858.CD004352.pub2] ">Anotayanonth 2004</a>). </p> <p>The ideal tocolytic agent should be effective, easy to administer, without significant maternal, fetal or neonatal side effects and permit time for antenatal corticosteroids to be administered and take effect (<a href="./references#CD006169-bbs2-0034" title="CrowtherCA , HillerJE , DoyleLW . Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD001060] ">Crowther 2002</a>). A variety of tocolytic treatments have been used to inhibit uterine activity in women in spontaneous preterm labour, including beta‐adrenergic receptor agonists (betamimetics), prostaglandin inhibitors, calcium channel blockers, oxytocin receptor antagonists and magnesium sulphate (<a href="./references#CD006169-bbs2-0028" title="AnotayanonthS , SubhedarNV , NeilsonJP , HarigopalS . Betamimetics for inhibiting preterm labour. Cochrane Database of Systematic Reviews2004, Issue 4. [DOI: 10.1002/14651858.CD004352.pub2] ">Anotayanonth 2004</a>; <a href="./references#CD006169-bbs2-0034" title="CrowtherCA , HillerJE , DoyleLW . Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD001060] ">Crowther 2002</a>; <a href="./references#CD006169-bbs2-0036" title="DuckittK , ThorntonS . Nitric oxide donors for the treatment of preterm labour. Cochrane Database of Systematic Reviews2002, Issue 3. [DOI: 10.1002/14651858.CD002860] ">Duckitt 2002</a>; <a href="./references#CD006169-bbs2-0038" title="FlenadyV , WojcieszekAM , PapatsonisDNM , StockOM , MurrayL , JardineLA , CarbonneB . Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database of Systematic Reviews2014, Issue 6. [DOI: 10.1002/14651858.CD002255.pub2] ">Flenady 2014</a>; <a href="./references#CD006169-bbs2-0039" title="FlenadyV , ReinebrantHE , LileyHG , TambimuttuEG , PapatsonisDNM . Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database of Systematic Reviews2014, Issue 6. [DOI: 10.1002/14651858.CD004452.pub3] ">Flenady 2014a</a>; <a href="./references#CD006169-bbs2-0040" title="Naik GaunekarN , RamanP , BainE , CrowtherCA . Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour. Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD004071.pub3] ">Gaunekar 2004</a>; <a href="./references#CD006169-bbs2-0046" title="KingJF , FlenadyV , ColeS , ThorntonS . Cyclo‐oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database of Systematic Reviews2005, Issue 2. [DOI: 10.1002/14651858.CD001992.pub2] ">King 2005</a>). However, there is considerable global variation in types, doses and regimens of tocolytic agents used to manage preterm labour. </p> </section> </section> <section id="CD006169-sec-0026"> <h3 class="title" id="CD006169-sec-0026">How the intervention might work</h3> <p>Uterine contractility is stimulated by increases in intracellular calcium ion concentrations in myometrial cells (<a href="./references#CD006169-bbs2-0042" title="GáspárR , Hajagos‐TóthJ . Calcium channel blockers as tocolytics: principles of their actions, adverse effects and therapeutic combinations. Pharmaceuticals (Basel)2013;6(6):689‐99. ">Gáspár 2013</a>). Intracellular calcium ion concentration is mediated by both voltage‐gated calcium channels (for influx of calcium ions) and release of calcium ions from sarcoplasmic reticulum. Calcium ions bind to calmodulin and activate myosin light chain kinase (MLCK) in myometrial cells, leading to the phosphorylation of myosin light chains, initiating cross‐bridging in contractile proteins and ultimately myometrial contraction (<a href="./references#CD006169-bbs2-0042" title="GáspárR , Hajagos‐TóthJ . Calcium channel blockers as tocolytics: principles of their actions, adverse effects and therapeutic combinations. Pharmaceuticals (Basel)2013;6(6):689‐99. ">Gáspár 2013</a>; <a href="./references#CD006169-bbs2-0049" title="NobleK , MatthewA , BurdygaT , WrayS . A review of recent insights into the role of the sarcoplasmic reticulum and Ca entry in uterine smooth muscle. European Journal of Obstetrics, Gynecology, and Reproductive Biology2009;144:S11‐S19. ">Noble 2009</a>; <a href="./references#CD006169-bbs2-0057" title="WrayS , JonesK , KupittayanantS , LiY , MatthewA , Monir‐BishtyE , et al. Calcium signalling and uterine contractility. Journal of the Society for Gynecologic Investigation2003;10:252‐64. ">Wray 2003</a>). </p> <p>Tocolytic agents inhibit uterine contractions through one of two pathways: Firstly, by affecting the contractile proteins in the myometrium (by blocking myosin phosphorylation through intracellular messengers). Betamimetics, nitric oxide donors, magnesium sulphate and calcium channel blockers affect contractile proteins. Betamimetics bind to beta‐adrenergic receptors (increasing intracellular cyclic adenosine monophosphate, that inhibits myosin light chain kinase) preventing myosin phosphorylation. Nitric oxide donors produce a similar response through cyclic guanosine monophosphate. Conversely, magnesium sulphate and calcium channel blockers prevent intracellular calcium ion influx, also reducing myosin light chain kinase activity (<a href="./references#CD006169-bbs2-0033" title="CaritisS . Adverse effects of tocolytic therapy. BJOG: an international journal of obstetrics and gynaecology2005;112(Suppl 1):74‐8. ">Caritis 2005</a>; <a href="./references#CD006169-bbs2-0042" title="GáspárR , Hajagos‐TóthJ . Calcium channel blockers as tocolytics: principles of their actions, adverse effects and therapeutic combinations. Pharmaceuticals (Basel)2013;6(6):689‐99. ">Gáspár 2013</a>). </p> <p>The second pathway to preventing uterine contractility is through inhibiting synthesis or blocking the activity of myometrial stimulants (such as oxytocin and prostaglandins). By binding oxytocin receptors, oxytocin receptor antagonists (such as atosiban) prevent the oxytocin‐mediated intracellular increase of inositol triphosphate, which normally increases intracellular calcium levels. Comparatively, cyclo‐oxygenase (COX) enzymes that catalyse prostaglandin production can be inhibited by general (COX) and selective (COX‐2) enzyme inhibitors (<a href="./references#CD006169-bbs2-0033" title="CaritisS . Adverse effects of tocolytic therapy. BJOG: an international journal of obstetrics and gynaecology2005;112(Suppl 1):74‐8. ">Caritis 2005</a>; <a href="./references#CD006169-bbs2-0042" title="GáspárR , Hajagos‐TóthJ . Calcium channel blockers as tocolytics: principles of their actions, adverse effects and therapeutic combinations. Pharmaceuticals (Basel)2013;6(6):689‐99. ">Gáspár 2013</a>). </p> <p>A combination of two or more tocolytic agents could be used to reduce uterine contractions by targeting different pathways in myometrial contraction, potentially improving the overall tocolytic effect (either additively or synergistically). Furthermore, combination therapy could permit reductions in dosage and/or frequency of individual tocolytic agents, potentially decreasing the rate of adverse effects while maintaining efficacy. </p> </section> <section id="CD006169-sec-0027"> <h3 class="title" id="CD006169-sec-0027">Why it is important to do this review</h3> <p>There is evidence that some tocolytic agents decrease the number of women in preterm labour giving birth within 48 hours when compared with placebo. This can increase the likelihood of receiving a full course of antenatal corticosteroids, as well as increase the time for antenatal corticosteroids to have a clinical effect. However, due to the lack of systematic reviews examining maternal and newborn morbidity and mortality outcomes following combination tocolytic use, inhibiting preterm labour with more than one tocolytic agent is currently based on an incomplete understanding of risks and benefits. Furthermore, combinations of tocolytic agents have the potential for greater efficacy compared to single agents, as well as the potential for reduced dosage and/or frequency of administration, that could reduce the rate of adverse effects. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006169-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006169-sec-0028"></div> <p>To assess the effects on maternal, fetal and neonatal outcomes of any combination of tocolytic drugs for the treatment of preterm labour compared with any other treatment, no treatment or placebo. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006169-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006169-sec-0029"></div> <section id="CD006169-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006169-sec-0031"> <h4 class="title">Types of studies</h4> <p>Any adequate published, unpublished or ongoing randomised controlled trial that compares a combination of tocolytic agents, administered by any route or any dose, for inhibiting preterm labour versus any other treatment (including other combinations of tocolytics, or single tocolytic), no intervention or placebo. We excluded quasi‐randomised controlled trials. </p> </section> <section id="CD006169-sec-0032"> <h4 class="title">Types of participants</h4> <p>Pregnant women assessed as being in spontaneous preterm labour (see definition below) and considered suitable for tocolytic agents. </p> </section> <section id="CD006169-sec-0033"> <h4 class="title">Types of interventions</h4> <p>The following groups of comparisons were assessed for inclusion.</p> <p> <ol id="CD006169-list-0001"> <li> <p>Combination of tocolytic drugs versus any other combination of tocolytic agents.</p> </li> <li> <p>Combination of tocolytic drugs versus any other tocolytic agent alone.</p> </li> <li> <p>Combination of tocolytic drugs versus any other intervention.</p> </li> <li> <p>Combination of tocolytic drugs versus no intervention.</p> </li> <li> <p>Combination of tocolytic drugs versus placebo.</p> </li> </ol> </p> </section> <section id="CD006169-sec-0034"> <h4 class="title">Types of outcome measures</h4> <p>Clinically relevant outcomes for trials of tocolysis for inhibiting preterm labour have been prespecified following consultation with the editors and authors of the individual reviews. </p> <p>Consensus was reached on a set of six ‘core’ outcomes, which are highlighted below. These will be included in all tocolysis reviews. In addition to these core outcomes, individual teams may include other outcomes as necessary. </p> <section id="CD006169-sec-0035"> <h5 class="title">Primary outcomes</h5> <p>Seven primary outcomes were chosen as being most representative of the clinically important measures of ineffectiveness and complications. </p> <p> <ol id="CD006169-list-0002"> <li> <p><b>Serious maternal outcomes</b> (see definition below). </p> </li> <li> <p>Short‐term and long‐term <b>serious infant outcome</b> (see definition below). </p> </li> <li> <p><b>Birth before 48 hours of trial entry</b>. </p> </li> <li> <p>Preterm neonate delivered without full course of antenatal steroids (see definition below) completed at least 24 hours before birth. </p> </li> <li> <p><b>Perinatal death after trial entry</b> (see definition below). </p> </li> <li> <p><b>Birth before 34 completed weeks</b>. </p> </li> <li> <p><b>Adverse drug reactions</b> (including discontinuation of therapy because of adverse effects). </p> </li> </ol> </p> <section id="CD006169-sec-0036"> <h6 class="title">Definitions</h6> <section id="CD006169-sec-0037"> <p><b>Preterm labour</b></p> <p>The presence of regular uterine contractions on a preterm pregnancy (with intact or ruptured membranes) with or without cervical dilatation. </p> </section> <section id="CD006169-sec-0038"> <p><b>Serious maternal outcomes</b></p> <p>Death, cardiac arrest, respiratory arrest, admission to intensive care unit.</p> </section> <section id="CD006169-sec-0039"> <p><b>Short‐term and long‐term serious infant outcome</b></p> <p>Determined by the presence of any of the following: death; chronic lung disease (use of supplemental oxygen therapy at 36 weeks' postmenstrual age or at 28 days of life or later); grade three or four intraventricular haemorrhage or periventricular leukomalacia; major sensorineural disability at two years of age defined as any one or more of the following: severe or profound vision impairment, sensorineural deafness requiring hearing aids, moderate or severe cerebral palsy or developmental delay/intellectual impairment (defined as developmental quotient or intelligence quotient less than two standard deviations below the mean). </p> </section> <section id="CD006169-sec-0040"> <p><b><i>Perinatal death after trial entry</i> </b></p> <p>Fetal death or neonatal death up to 28 days of life.</p> </section> <section id="CD006169-sec-0041"> <p><b>Full course of corticosteroids</b></p> <p>Betamethasone (24 mg) intramuscularly (IM) divided in two to four doses, given in 24 hours, 20 to 24 mg of dexamethasone IM divided in four to six doses given in 24 hours, or 2 g of hydrocortisone intravenously divided in four doses given in 24 hours. </p> </section> </section> </section> <section id="CD006169-sec-0042"> <h5 class="title">Secondary outcomes</h5> <section id="CD006169-sec-0043"> <h6 class="title">Maternal</h6> <p> <ol id="CD006169-list-0003"> <li> <p>Need for additional tocolytics.</p> </li> <li> <p>Recurrence of labour.</p> </li> <li> <p>Caesarean section birth.</p> </li> <li> <p>Antepartum haemorrhage.</p> </li> <li> <p>Postpartum haemorrhage.</p> </li> <li> <p>Length of hospital stay.</p> </li> <li> <p>Breastfeeding.</p> </li> <li> <p>Satisfaction with treatment.</p> </li> <li> <p>Quality of life at 12 to 24 months after the birth (measured by validated instruments).</p> </li> <li> <p>Psychological aspects of mother and family.</p> </li> <li> <p>Maternal oedema (non‐prespecified outcome).</p> </li> </ol> </p> </section> <section id="CD006169-sec-0044"> <h6 class="title">Infant/child</h6> <p> <ol id="CD006169-list-0004"> <li> <p>Preterm neonate delivered without full course of antenatal steroids (see definition below) completed at least 24 hours before birth. </p> </li> <li> <p>Birth before seven days of trial entry.</p> </li> <li> <p>Birth before 28 completed weeks.</p> </li> <li> <p>Birth before 37 completed weeks.</p> </li> <li> <p>Pregnancy prolongation (latency: interval between randomisation and birth).</p> </li> <li> <p>Gestational age at birth.</p> </li> <li> <p>Birthweight.</p> </li> <li> <p>Apgar score less than seven at five minutes.</p> </li> <li> <p>Respiratory distress syndrome.</p> </li> <li> <p>Use of mechanical ventilation.</p> </li> <li> <p>Duration of mechanical ventilation.</p> </li> <li> <p>Persistent pulmonary hypertension of the neonate.</p> </li> <li> <p>Intraventricular haemorrhage.</p> </li> <li> <p>Intraventricular haemorrhage ‐ grade three or four.</p> </li> <li> <p>Periventricular leukomalacia.</p> </li> <li> <p>Chronic lung disease.</p> </li> <li> <p>Necrotising enterocolitis.</p> </li> <li> <p>Retinopathy of prematurity.</p> </li> <li> <p>Neonatal jaundice.</p> </li> <li> <p>Neonatal sepsis.</p> </li> <li> <p>Fetal death.</p> </li> <li> <p>Neonatal death.</p> </li> <li> <p>Infant death.</p> </li> <li> <p>Arterial pH &lt; 7.1 (non pre‐specified).</p> </li> </ol> </p> </section> <section id="CD006169-sec-0045"> <h6 class="title">Health service use</h6> <p> <ol id="CD006169-list-0005"> <li> <p>Admission to neonatal intensive care unit.</p> </li> <li> <p>Neonatal length of hospital stay.</p> </li> <li> <p>Treatment associated costs.</p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD006169-sec-0046"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD006169-sec-0047"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register by contacting the Trials Search Co‐ordinator (31 January 2014). </p> <p>The Cochrane Pregnancy and Childbirth Group’s Trials Register is maintained by the Trials Search Co‐ordinator and contains trials identified from: </p> <p> <ol id="CD006169-list-0006"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE;</p> </li> <li> <p>weekly searches of Embase;</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Details of the search strategies for CENTRAL, MEDLINE and Embase, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the ‘Specialized Register’ section within the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth Group</a>. </p> <p>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co‐ordinator searches the register for each review using the topic list rather than keywords. </p> </section> <section id="CD006169-sec-0048"> <h4 class="title">Searching other resources</h4> <p>We searched reference lists of retrieved studies.</p> <p>We did not apply any language restrictions.</p> </section> </section> <section id="CD006169-sec-0049"> <h3 class="title" id="CD006169-sec-0049">Data collection and analysis</h3> <section id="CD006169-sec-0050"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed for inclusion all the potential studies identify as a result of the search strategy. We resolved any disagreement through discussion. </p> </section> <section id="CD006169-sec-0051"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data. For eligible studies, review authors (J Nardin (JN), H West (HW), T Dowswell (TD)) extracted the data using the agreed form. We resolved discrepancies through discussion. We entered data into Review Manager software (<a href="./references#CD006169-bbs2-0052" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>) and checked them for accuracy. </p> <p>When information regarding any of the above was unclear, we attempted to contact authors of the original reports to provide further details. </p> </section> <section id="CD006169-sec-0052"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (HW, TD) independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006169-bbs2-0044" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We resolved any disagreement by discussion. </p> <section id="CD006169-sec-0053"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD006169-list-0007"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.   </p> </li> </ul> </p> </section> <section id="CD006169-sec-0054"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal the allocation sequence and determined whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD006169-list-0008"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.   </p> </li> </ul> </p> </section> <section id="CD006169-sec-0055"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding would be unlikely to affect the results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD006169-list-0009"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear for personnel.</p> </li> </ul> </p> </section> <section id="CD006169-sec-0056"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as:</p> <p> <ul id="CD006169-list-0010"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD006169-sec-0057"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We state whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or was supplied by the trial authors, we re‐included missing data in the analyses which we undertook. We assessed methods as: </p> <p> <ul id="CD006169-list-0011"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; 'as treated' analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD006169-sec-0058"> <h5 class="title">(5) Selective reporting bias (checking for reporting bias)</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD006169-list-0012"> <li> <p>low risk of bias (where it was clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD006169-sec-0059"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We described for each included study any important concerns we have about other possible sources of bias. </p> <p>We assessed whether each study was free of other problems that could put it at risk of bias: </p> <p> <ul id="CD006169-list-0013"> <li> <p>low risk of other bias;</p> </li> <li> <p>high risk of other bias;</p> </li> <li> <p>unclear whether there is risk of other bias.</p> </li> </ul> </p> </section> <section id="CD006169-sec-0060"> <h5 class="title">(7) Overall risk of bias</h5> <p>We have made explicit judgements about whether studies are at high risk of bias, according to the criteria given in the <i>Handbook</i> (<a href="./references#CD006169-bbs2-0044" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we consider it likely to impact on the findings. We planned to explore the impact of the level of bias through undertaking sensitivity analyses ‐ see <a href="#CD006169-sec-0071">Sensitivity analysis</a>. </p> </section> </section> <section id="CD006169-sec-0061"> <h4 class="title">Measures of treatment effect</h4> <section id="CD006169-sec-0062"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals. </p> </section> <section id="CD006169-sec-0063"> <h5 class="title">Continuous data</h5> <p>For continuous data, we used the mean difference if outcomes are measured in the same way between trials. We planned to use the standardised mean difference to combine trials that measured the same outcome using different methods. <b> </b> </p> </section> </section> <section id="CD006169-sec-0064"> <h4 class="title">Unit of analysis issues</h4> <section id="CD006169-sec-0065"> <h5 class="title">Cluster‐randomised trials</h5> <p>We did not identify any cluster‐randomised trials for inclusion in this review. If we identify cluster‐randomised trials for inclusion in a subsequent update of this review, we will include them in the analyses along with individually‐randomised trials. We will adjust their sample sizes using the methods described in the <i>Handbook</i> (<a href="./references#CD006169-bbs2-0044" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) using an estimate of the intra‐cluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation on the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. </p> <p>We will also acknowledge heterogeneity in the randomisation unit and perform a subgroup analysis to investigate the effects of the randomisation unit. </p> <p>We planned to use methods used for the analysis of cluster‐randomised trials to analyse data from trials which included more than 10% multiple pregnancies provided information was available (in the trial reports or from authors) on outcomes for twins or higher multiples. In this version of the review no such trials were included; trials either explicitly excluded women with multiple pregnancies or there was insufficient information to carry out planned analysis. </p> </section> </section> <section id="CD006169-sec-0066"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. We planned to explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis. </p> <p>For all outcomes, we carried out analyses, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomised to each group in the analyses, and all participants were analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial is the number randomised minus any participants whose outcomes are known to be missing. </p> </section> <section id="CD006169-sec-0067"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if an I² was greater than 30% and either a Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. </p> </section> <section id="CD006169-sec-0068"> <h4 class="title">Assessment of reporting biases</h4> <p>In future updates of this review, if there are 10 or more studies in the meta‐analysis we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it. </p> </section> <section id="CD006169-sec-0069"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using the Review Manager software (<a href="./references#CD006169-bbs2-0052" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). We use fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials examined the same intervention, and the trials’ populations and methods were judged sufficiently similar. If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we planned to use random‐effects meta‐analysis to produce an overall summary if an average treatment effect across trials was considered clinically meaningful. If the average treatment effect was not clinically meaningful, we did not combine trials. </p> </section> <section id="CD006169-sec-0070"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If we had identified substantial heterogeneity, we planned to investigate it using subgroup analyses and sensitivity analyses. </p> <p>We planned to carry out the following subgroup analyses.</p> <p> <ol id="CD006169-list-0014"> <li> <p>Gestational age (less than 28 weeks of gestation versus 28 weeks and above).</p> </li> <li> <p>Intact versus ruptured membranes.</p> </li> <li> <p>Single versus multiple pregnancy.</p> </li> </ol> </p> <p>We planned to restrict subgroup analyses to the primary outcomes.</p> <p>However, only one trial reported data that could be analysed based on the status of the membranes and in view of heterogeneity, we have presented results for these subgroups separately (<a href="./references#CD006169-bbs2-0006" title="GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. European Journal of Obstetrics and Gynecology and Reproductive Biology1978;8:123‐8. GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. Proceedings of the 6th European Congress of Perinatal Medicine, August 29th‐September 1st. Vienna, Austria, 1978. GamissansO , CararachV , SerraJ . The role of prostaglandin‐inhibitors, beta‐adrenergic drugs and glucocorticoids in the management of threatened preterm labor. Beta‐mimetic Drugs in Obstetrics and Perinatology. 3rd Symposium on Beta‐mimetic Drugs, Aagen, November 1980. Thieme‐Stratton Inc, 1982:71‐84. ">Gamissans 1982</a>). Planned subgroup analyses will be carried out in future updates of this review if more data become available. </p> <p>We planned to assess differences between subgroups by interaction tests available in <a href="./references#CD006169-bbs2-0052" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>. We would have reported the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value. </p> </section> <section id="CD006169-sec-0071"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to carry out sensitivity analysis to explore the effect of trial quality. This would involve analysis based on the rating of selection bias and attrition bias. Studies of poor quality (those rated as 'unclear' or 'high risk of bias') would be excluded in the analysis in order to assess for any substantive difference to the overall result. However, all of the included trials were rated as unclear or high risk of bias for selection and/or attrition bias, therefore, no sensitivity analyses were performed </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006169-sec-0072" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006169-sec-0072"></div> <section id="CD006169-sec-0073"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD006169-sec-0122" title="">Characteristics of included studies</a> and <a href="./references#CD006169-sec-0123" title="">Characteristics of excluded studies</a>. </p> <section id="CD006169-sec-0074"> <h4 class="title">Results of the search</h4> <p>Our search strategy identified 31 citations corresponding to 27 studies that were assessed for inclusion. While 11 studies (14 citations) met our inclusion criteria, two of these did not report any outcome data relevant to the review (<a href="./references#CD006169-bbs2-0003" title="CastilloJM , AlonsoJ , Hernandez‐GarciaJM , SanchoB , MartinezV . Study of biochemical and biophysical modifications produced on pregnant women treated in threatened of premature labor with ritodrine and indometacine. 12th World Congress of Gynecology and Obstetrics; 1988 Oct 23‐28; Rio de Janeiro, Brazil. 1988:20. ">Castillo 1988</a>; <a href="./references#CD006169-bbs2-0011" title="SchaufB , BeckerS , AbeleH , KleverT , WallwienerD , AydenizB . Effect of magnesium on red blood cell deformability in pregnancy. Hypertension in Pregnancy2005;24(1):17‐27. ">Schauf 2005</a>). Further information about both of these trials is set out in the <a href="./references#CD006169-sec-0122" title="">Characteristics of included studies</a> tables, but these studies do not contribute any data to the analyses, and are not otherwise mentioned in the results below. Sixteen studies (17 citations) were excluded (see: <a href="#CD006169-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD006169-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD006169-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>Results are based on nine included trials that contributed data. Some of these studies reported on very few of our pre‐specified primary and secondary outcomes, and for most outcomes only one study contributed data so, overall, very few data were pooled in meta‐analysis. </p> </section> <section id="CD006169-sec-0075"> <h4 class="title">Included studies</h4> <p>The included studies were categorised according to the type of drugs being compared.</p> <p> <ol id="CD006169-list-0015"> <li> <p>Intravenous (IV) ritodrine plus oral or IV magnesium (gluconate or sulphate) versus IV ritodrine alone: three trials, including a total of 231 women (<a href="./references#CD006169-bbs2-0001" title="AllyK , NicolasA , ThoumsinH , LambotteR . Magnesium gluconate and intravenous tocolysis with ritodrine. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1992;21:370‐4. ">Ally 1992</a>; <a href="./references#CD006169-bbs2-0004" title="FergusonJE , HensleighPA , KredensterD . Adjunctive use of magnesium sulfate with ritodrine for preterm labor tocolysis. American Journal of Obstetrics and Gynecology1984;148(2):166‐71. FergusonJE , HolbrookH , StevensonDK , HensleighPA , KredentserD . Adjunctive magnesium sulphate infusion does not alter metabolic changes associated with ritodrine tocolysis. American Journal of Obstetrics and Gynecology1987;156:103‐7. ">Ferguson 1984</a>; <a href="./references#CD006169-bbs2-0007" title="HatjisCG , SwainM , NelsonLH , MeisPJ , ErnestJM . Efficacy of combined administration of magnesium sulfate and ritodrine in the treatment of premature labor. Obstetrics and Gynecology1987;69:317‐22. ">Hatjis 1987</a>). </p> </li> <li> <p>IV ritodrine plus indomethacin suppositories versus IV ritodrine alone: one trial, including 208 women (<a href="./references#CD006169-bbs2-0006" title="GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. European Journal of Obstetrics and Gynecology and Reproductive Biology1978;8:123‐8. GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. Proceedings of the 6th European Congress of Perinatal Medicine, August 29th‐September 1st. Vienna, Austria, 1978. GamissansO , CararachV , SerraJ . The role of prostaglandin‐inhibitors, beta‐adrenergic drugs and glucocorticoids in the management of threatened preterm labor. Beta‐mimetic Drugs in Obstetrics and Perinatology. 3rd Symposium on Beta‐mimetic Drugs, Aagen, November 1980. Thieme‐Stratton Inc, 1982:71‐84. ">Gamissans 1982</a>). </p> </li> <li> <p>IV ritodrine plus vaginal progesterone versus IV ritodrine alone: one trial with 83 women (<a href="./references#CD006169-bbs2-0002" title="ArikanI , BarutA , HarmaM , HarmaIM . Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor. Gynecologic and Obstetric Investigation2011;72(4):269‐73. ">Arikan 2011</a>). </p> </li> <li> <p>IV hexoprenaline sulphate plus IV magnesium hydrochloride versus IV hexoprenaline sulphate alone: one trial, including a total of 24 women (<a href="./references#CD006169-bbs2-0005" title="FrancioliM , DeMeuronA . Usefulness of the addition of aspartate magnesium hydrochloride via intravenous route to beta mimetics in the treatment of threatened preterm labor. Revue Medicale de la Suisse Romande1988;108:283‐9. ">Francioli 1988</a>). </p> </li> <li> <p>IV fenoterol plus oral naproxen versus IV fenoterol alone: one trial, including 72 women (<a href="./references#CD006169-bbs2-0009" title="Rios‐AnezR , Santos‐LuqueM , NogueraME . Use of an antagonist of the prostaglandins associated to a b‐sympathomimetic agent in the treatment of pre‐term labour [abstract]. Journal of Perinatal Medicine2001;29 Suppl 1(Pt 1):165. ">Rios‐Anez 2001</a>). </p> </li> <li> <p>Oral pentoxifylline plus IV magnesium sulphate plus IV fenoterol versus IV magnesium sulphate plus IV fenoterol: one trial with 125 women (<a href="./references#CD006169-bbs2-0008" title="LauterbachR , RytlewskiK , PawlikD , HurkalaJ , WojtowiczA , BreborowiczG , et al. Effect of Pentoxifylline, administered in preterm labour, on the foetal‐placental circulation and neonatal outcome: a randomized, prospective pilot study. Basic and Clinical Pharmacology and Toxicology2012;110(4):342‐6. ">Lauterbach 2012</a>). </p> </li> <li> <p>IV terbutaline plus oral metoprolol versus IV terbutaline alone: one trial with data for 17 women (<a href="./references#CD006169-bbs2-0010" title="RossMG , NicollsE , StubblefieldPG , KitzmillerJL . Intravenous terbutaline and simultaneous beta‐blockade for advanced premature labor. American Journal of Obstetrics and Gynecology1983;147:897‐902. ">Ross 1983</a>). </p> </li> </ol> </p> <section id="CD006169-sec-0076"> <h5 class="title">Settings</h5> <p>The studies were reported between 1982 and 2012 in six countries (USA (<a href="./references#CD006169-bbs2-0004" title="FergusonJE , HensleighPA , KredensterD . Adjunctive use of magnesium sulfate with ritodrine for preterm labor tocolysis. American Journal of Obstetrics and Gynecology1984;148(2):166‐71. FergusonJE , HolbrookH , StevensonDK , HensleighPA , KredentserD . Adjunctive magnesium sulphate infusion does not alter metabolic changes associated with ritodrine tocolysis. American Journal of Obstetrics and Gynecology1987;156:103‐7. ">Ferguson 1984</a>; <a href="./references#CD006169-bbs2-0007" title="HatjisCG , SwainM , NelsonLH , MeisPJ , ErnestJM . Efficacy of combined administration of magnesium sulfate and ritodrine in the treatment of premature labor. Obstetrics and Gynecology1987;69:317‐22. ">Hatjis 1987</a>; <a href="./references#CD006169-bbs2-0010" title="RossMG , NicollsE , StubblefieldPG , KitzmillerJL . Intravenous terbutaline and simultaneous beta‐blockade for advanced premature labor. American Journal of Obstetrics and Gynecology1983;147:897‐902. ">Ross 1983</a>); France (<a href="./references#CD006169-bbs2-0001" title="AllyK , NicolasA , ThoumsinH , LambotteR . Magnesium gluconate and intravenous tocolysis with ritodrine. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1992;21:370‐4. ">Ally 1992</a>; <a href="./references#CD006169-bbs2-0005" title="FrancioliM , DeMeuronA . Usefulness of the addition of aspartate magnesium hydrochloride via intravenous route to beta mimetics in the treatment of threatened preterm labor. Revue Medicale de la Suisse Romande1988;108:283‐9. ">Francioli 1988</a>); Turkey (<a href="./references#CD006169-bbs2-0002" title="ArikanI , BarutA , HarmaM , HarmaIM . Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor. Gynecologic and Obstetric Investigation2011;72(4):269‐73. ">Arikan 2011</a>); Spain (<a href="./references#CD006169-bbs2-0006" title="GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. European Journal of Obstetrics and Gynecology and Reproductive Biology1978;8:123‐8. GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. Proceedings of the 6th European Congress of Perinatal Medicine, August 29th‐September 1st. Vienna, Austria, 1978. GamissansO , CararachV , SerraJ . The role of prostaglandin‐inhibitors, beta‐adrenergic drugs and glucocorticoids in the management of threatened preterm labor. Beta‐mimetic Drugs in Obstetrics and Perinatology. 3rd Symposium on Beta‐mimetic Drugs, Aagen, November 1980. Thieme‐Stratton Inc, 1982:71‐84. ">Gamissans 1982</a>); Poland (<a href="./references#CD006169-bbs2-0008" title="LauterbachR , RytlewskiK , PawlikD , HurkalaJ , WojtowiczA , BreborowiczG , et al. Effect of Pentoxifylline, administered in preterm labour, on the foetal‐placental circulation and neonatal outcome: a randomized, prospective pilot study. Basic and Clinical Pharmacology and Toxicology2012;110(4):342‐6. ">Lauterbach 2012</a>); and Venezuela (<a href="./references#CD006169-bbs2-0009" title="Rios‐AnezR , Santos‐LuqueM , NogueraME . Use of an antagonist of the prostaglandins associated to a b‐sympathomimetic agent in the treatment of pre‐term labour [abstract]. Journal of Perinatal Medicine2001;29 Suppl 1(Pt 1):165. ">Rios‐Anez 2001</a>). </p> </section> <section id="CD006169-sec-0077"> <h5 class="title">Participants</h5> <p>All of the studies recruited women in preterm labour. All studies recruited women with a gestational age less than 37 weeks, but the criteria relating to gestation varied particularly with regard to the lower gestational age (22 to 35 weeks (<a href="./references#CD006169-bbs2-0001" title="AllyK , NicolasA , ThoumsinH , LambotteR . Magnesium gluconate and intravenous tocolysis with ritodrine. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1992;21:370‐4. ">Ally 1992</a>); 24 to 34 weeks (<a href="./references#CD006169-bbs2-0002" title="ArikanI , BarutA , HarmaM , HarmaIM . Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor. Gynecologic and Obstetric Investigation2011;72(4):269‐73. ">Arikan 2011</a>); up to 36 weeks (<a href="./references#CD006169-bbs2-0004" title="FergusonJE , HensleighPA , KredensterD . Adjunctive use of magnesium sulfate with ritodrine for preterm labor tocolysis. American Journal of Obstetrics and Gynecology1984;148(2):166‐71. FergusonJE , HolbrookH , StevensonDK , HensleighPA , KredentserD . Adjunctive magnesium sulphate infusion does not alter metabolic changes associated with ritodrine tocolysis. American Journal of Obstetrics and Gynecology1987;156:103‐7. ">Ferguson 1984</a>); 28 to 36 weeks (<a href="./references#CD006169-bbs2-0005" title="FrancioliM , DeMeuronA . Usefulness of the addition of aspartate magnesium hydrochloride via intravenous route to beta mimetics in the treatment of threatened preterm labor. Revue Medicale de la Suisse Romande1988;108:283‐9. ">Francioli 1988</a>); 20 to 36 weeks (<a href="./references#CD006169-bbs2-0006" title="GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. European Journal of Obstetrics and Gynecology and Reproductive Biology1978;8:123‐8. GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. Proceedings of the 6th European Congress of Perinatal Medicine, August 29th‐September 1st. Vienna, Austria, 1978. GamissansO , CararachV , SerraJ . The role of prostaglandin‐inhibitors, beta‐adrenergic drugs and glucocorticoids in the management of threatened preterm labor. Beta‐mimetic Drugs in Obstetrics and Perinatology. 3rd Symposium on Beta‐mimetic Drugs, Aagen, November 1980. Thieme‐Stratton Inc, 1982:71‐84. ">Gamissans 1982</a>); 20 to 35 weeks (<a href="./references#CD006169-bbs2-0007" title="HatjisCG , SwainM , NelsonLH , MeisPJ , ErnestJM . Efficacy of combined administration of magnesium sulfate and ritodrine in the treatment of premature labor. Obstetrics and Gynecology1987;69:317‐22. ">Hatjis 1987</a>); 23 to 34 weeks (<a href="./references#CD006169-bbs2-0008" title="LauterbachR , RytlewskiK , PawlikD , HurkalaJ , WojtowiczA , BreborowiczG , et al. Effect of Pentoxifylline, administered in preterm labour, on the foetal‐placental circulation and neonatal outcome: a randomized, prospective pilot study. Basic and Clinical Pharmacology and Toxicology2012;110(4):342‐6. ">Lauterbach 2012</a>); 31 to 36 weeks (<a href="./references#CD006169-bbs2-0009" title="Rios‐AnezR , Santos‐LuqueM , NogueraME . Use of an antagonist of the prostaglandins associated to a b‐sympathomimetic agent in the treatment of pre‐term labour [abstract]. Journal of Perinatal Medicine2001;29 Suppl 1(Pt 1):165. ">Rios‐Anez 2001</a>) and 26 to 36 weeks (<a href="./references#CD006169-bbs2-0010" title="RossMG , NicollsE , StubblefieldPG , KitzmillerJL . Intravenous terbutaline and simultaneous beta‐blockade for advanced premature labor. American Journal of Obstetrics and Gynecology1983;147:897‐902. ">Ross 1983</a>). </p> <p>In one trial it was specifically stated that women with both intact and ruptured amniotic membranes were included (<a href="./references#CD006169-bbs2-0006" title="GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. European Journal of Obstetrics and Gynecology and Reproductive Biology1978;8:123‐8. GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. Proceedings of the 6th European Congress of Perinatal Medicine, August 29th‐September 1st. Vienna, Austria, 1978. GamissansO , CararachV , SerraJ . The role of prostaglandin‐inhibitors, beta‐adrenergic drugs and glucocorticoids in the management of threatened preterm labor. Beta‐mimetic Drugs in Obstetrics and Perinatology. 3rd Symposium on Beta‐mimetic Drugs, Aagen, November 1980. Thieme‐Stratton Inc, 1982:71‐84. ">Gamissans 1982</a>); however, four studies specifically mentioned excluding women with preterm prelabour rupture of membranes (<a href="./references#CD006169-bbs2-0001" title="AllyK , NicolasA , ThoumsinH , LambotteR . Magnesium gluconate and intravenous tocolysis with ritodrine. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1992;21:370‐4. ">Ally 1992</a>; <a href="./references#CD006169-bbs2-0002" title="ArikanI , BarutA , HarmaM , HarmaIM . Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor. Gynecologic and Obstetric Investigation2011;72(4):269‐73. ">Arikan 2011</a>; <a href="./references#CD006169-bbs2-0005" title="FrancioliM , DeMeuronA . Usefulness of the addition of aspartate magnesium hydrochloride via intravenous route to beta mimetics in the treatment of threatened preterm labor. Revue Medicale de la Suisse Romande1988;108:283‐9. ">Francioli 1988</a>; <a href="./references#CD006169-bbs2-0010" title="RossMG , NicollsE , StubblefieldPG , KitzmillerJL . Intravenous terbutaline and simultaneous beta‐blockade for advanced premature labor. American Journal of Obstetrics and Gynecology1983;147:897‐902. ">Ross 1983</a>) and in the remaining studies, it was not clear whether inclusion was confined to women with intact membranes. Five studies specifically mentioned exclusion of women with multiple pregnancies (<a href="./references#CD006169-bbs2-0002" title="ArikanI , BarutA , HarmaM , HarmaIM . Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor. Gynecologic and Obstetric Investigation2011;72(4):269‐73. ">Arikan 2011</a>; <a href="./references#CD006169-bbs2-0005" title="FrancioliM , DeMeuronA . Usefulness of the addition of aspartate magnesium hydrochloride via intravenous route to beta mimetics in the treatment of threatened preterm labor. Revue Medicale de la Suisse Romande1988;108:283‐9. ">Francioli 1988</a>; <a href="./references#CD006169-bbs2-0006" title="GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. European Journal of Obstetrics and Gynecology and Reproductive Biology1978;8:123‐8. GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. Proceedings of the 6th European Congress of Perinatal Medicine, August 29th‐September 1st. Vienna, Austria, 1978. GamissansO , CararachV , SerraJ . The role of prostaglandin‐inhibitors, beta‐adrenergic drugs and glucocorticoids in the management of threatened preterm labor. Beta‐mimetic Drugs in Obstetrics and Perinatology. 3rd Symposium on Beta‐mimetic Drugs, Aagen, November 1980. Thieme‐Stratton Inc, 1982:71‐84. ">Gamissans 1982</a>; <a href="./references#CD006169-bbs2-0008" title="LauterbachR , RytlewskiK , PawlikD , HurkalaJ , WojtowiczA , BreborowiczG , et al. Effect of Pentoxifylline, administered in preterm labour, on the foetal‐placental circulation and neonatal outcome: a randomized, prospective pilot study. Basic and Clinical Pharmacology and Toxicology2012;110(4):342‐6. ">Lauterbach 2012</a>; <a href="./references#CD006169-bbs2-0009" title="Rios‐AnezR , Santos‐LuqueM , NogueraME . Use of an antagonist of the prostaglandins associated to a b‐sympathomimetic agent in the treatment of pre‐term labour [abstract]. Journal of Perinatal Medicine2001;29 Suppl 1(Pt 1):165. ">Rios‐Anez 2001</a>). Women with serious complications or disease (including infection and renal problems) were specifically excluded by <a href="./references#CD006169-bbs2-0001" title="AllyK , NicolasA , ThoumsinH , LambotteR . Magnesium gluconate and intravenous tocolysis with ritodrine. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1992;21:370‐4. ">Ally 1992</a>; <a href="./references#CD006169-bbs2-0002" title="ArikanI , BarutA , HarmaM , HarmaIM . Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor. Gynecologic and Obstetric Investigation2011;72(4):269‐73. ">Arikan 2011</a>; <a href="./references#CD006169-bbs2-0006" title="GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. European Journal of Obstetrics and Gynecology and Reproductive Biology1978;8:123‐8. GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. Proceedings of the 6th European Congress of Perinatal Medicine, August 29th‐September 1st. Vienna, Austria, 1978. GamissansO , CararachV , SerraJ . The role of prostaglandin‐inhibitors, beta‐adrenergic drugs and glucocorticoids in the management of threatened preterm labor. Beta‐mimetic Drugs in Obstetrics and Perinatology. 3rd Symposium on Beta‐mimetic Drugs, Aagen, November 1980. Thieme‐Stratton Inc, 1982:71‐84. ">Gamissans 1982</a>; <a href="./references#CD006169-bbs2-0008" title="LauterbachR , RytlewskiK , PawlikD , HurkalaJ , WojtowiczA , BreborowiczG , et al. Effect of Pentoxifylline, administered in preterm labour, on the foetal‐placental circulation and neonatal outcome: a randomized, prospective pilot study. Basic and Clinical Pharmacology and Toxicology2012;110(4):342‐6. ">Lauterbach 2012</a>; and <a href="./references#CD006169-bbs2-0010" title="RossMG , NicollsE , StubblefieldPG , KitzmillerJL . Intravenous terbutaline and simultaneous beta‐blockade for advanced premature labor. American Journal of Obstetrics and Gynecology1983;147:897‐902. ">Ross 1983</a>. Other exclusion criteria included previous uterine or cervical surgery, fetal anomaly and deteriorating condition of the mother or fetus. </p> </section> <section id="CD006169-sec-0078"> <h5 class="title">Interventions</h5> <p>All of the trials included therapy through intravenous infusion in at least one of the groups, and in most trials there was maintenance therapy with oral drugs following successful tocolysis. Dosage and duration of initial tocolysis varied, and several trials mentioned adjusting infusion rates depending on side effects and the effect of tocolysis on uterine contractions. Co‐interventions were not always well described. Use of corticosteroids (betamethasone or dexamethasone) for fetal lung maturation were mentioned by <a href="./references#CD006169-bbs2-0002" title="ArikanI , BarutA , HarmaM , HarmaIM . Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor. Gynecologic and Obstetric Investigation2011;72(4):269‐73. ">Arikan 2011</a>; <a href="./references#CD006169-bbs2-0004" title="FergusonJE , HensleighPA , KredensterD . Adjunctive use of magnesium sulfate with ritodrine for preterm labor tocolysis. American Journal of Obstetrics and Gynecology1984;148(2):166‐71. FergusonJE , HolbrookH , StevensonDK , HensleighPA , KredentserD . Adjunctive magnesium sulphate infusion does not alter metabolic changes associated with ritodrine tocolysis. American Journal of Obstetrics and Gynecology1987;156:103‐7. ">Ferguson 1984</a>; <a href="./references#CD006169-bbs2-0006" title="GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. European Journal of Obstetrics and Gynecology and Reproductive Biology1978;8:123‐8. GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. Proceedings of the 6th European Congress of Perinatal Medicine, August 29th‐September 1st. Vienna, Austria, 1978. GamissansO , CararachV , SerraJ . The role of prostaglandin‐inhibitors, beta‐adrenergic drugs and glucocorticoids in the management of threatened preterm labor. Beta‐mimetic Drugs in Obstetrics and Perinatology. 3rd Symposium on Beta‐mimetic Drugs, Aagen, November 1980. Thieme‐Stratton Inc, 1982:71‐84. ">Gamissans 1982</a>; <a href="./references#CD006169-bbs2-0008" title="LauterbachR , RytlewskiK , PawlikD , HurkalaJ , WojtowiczA , BreborowiczG , et al. Effect of Pentoxifylline, administered in preterm labour, on the foetal‐placental circulation and neonatal outcome: a randomized, prospective pilot study. Basic and Clinical Pharmacology and Toxicology2012;110(4):342‐6. ">Lauterbach 2012</a>; and <a href="./references#CD006169-bbs2-0010" title="RossMG , NicollsE , StubblefieldPG , KitzmillerJL . Intravenous terbutaline and simultaneous beta‐blockade for advanced premature labor. American Journal of Obstetrics and Gynecology1983;147:897‐902. ">Ross 1983</a>. In the remaining studies it was not clear whether or not women received corticosteroids during the first 24 hours of tocolytic therapy. </p> </section> <section id="CD006169-sec-0079"> <h5 class="title">Outcomes</h5> <p>All of the studies included some measure of pregnancy prolongation, although this was not measured consistently in different studies. Other pre‐specified outcomes were not consistently reported across studies. Side effects were reported in a minority of trials, and fewer than half of the included studies reported infant mortality and serious morbidity. </p> </section> </section> <section id="CD006169-sec-0080"> <h4 class="title">Excluded studies</h4> <p>We excluded 16 studies. The main reason for exclusion was that the method of allocation was not random; this applied to 11 studies (<a href="./references#CD006169-bbs2-0013" title="CaballeroA , TejerinaA , DominguezA , NavaJM , CaballeroAJr . Indomethacine alone or associated to ritodrine in the prevention of premature labour [abstract]. 9th World Congress of Gynecology and Obstetrics; 1979 Oct 26‐31;Tokyo, Japan. 1979:300. ">Caballero 1979</a>; <a href="./references#CD006169-bbs2-0016" title="HowHY , ZafaranchiL , StellaCL , RechtK , MaxwellRA , SibaiBM , et al. Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: a randomized controlled pilot study. American Journal of Obstetrics and Gynecology2006;194(4):976‐81. ">How 2006</a>; <a href="./references#CD006169-bbs2-0017" title="IedaK , SasakiJ , MizunoS , MimuraS , SuzukiC , MiyazakiT , et al. The clinical effects of maternally administered magnesium sulfate on the neonate. Journal of Perinatal Medicine1991;Suppl 2:225. ">Ieda 1991</a>; <a href="./references#CD006169-bbs2-0018" title="IlliaR , DeDiegoI , SolanaC . Threatened preterm labour. Evaluation of perinatals results in patients treated with betamimetics only and associated with indometacin [Amenaza de parto pretérmino. Evaluación de resultados perinatales de pacientes tratadas con betamiméticos solos y asociados a indometacina]. Tokoginecologia Practica1993;52:383‐7. ">Illia 1993</a>; <a href="./references#CD006169-bbs2-0019" title="KatzZ , LancetM , YeminiM , MogilnerBM , FeiglA , Ben‐HurH . Treatment of premature labor contractions with combined ritodrine and indomethacine. International Journal of Gynecology &amp; Obstetrics1983;21:337‐42. ">Katz 1983</a>; <a href="./references#CD006169-bbs2-0022" title="OgburnPLJr , HansenCA , WilliamsPP , ButlerJCJr , JosephMS , JulianTM . Magnesium sulfate and beta‐mimetic dual‐agent tocolysis in preterm labor after single‐agent failure. Journal of Reproductive Medicine1985;30(8):583‐7. ">Ogburn 1985</a>; <a href="./references#CD006169-bbs2-0023" title="ReynoldsJW . A comparison of salbutamol and ethanol in the treatment of premature labour. Australian and New Zealand Journal of Obstetrics and Gynaecology1978;18:107‐9. ">Reynolds 1978</a>; <a href="./references#CD006169-bbs2-0024" title="RichterR , HammacherK , HinselmannM . Prophylaxis of threatened premature labour. Clinical results in a prospective comparative study with ritodrine and buphenine. Gynakologische Rundschau1975;15:58‐9. ">Richter 1975</a>; <a href="./references#CD006169-bbs2-0025" title="RichterR , HinselmannMJ . The treatment of threatened premature labor by betamimetic drugs: a comparison of fenoterol and ritodrine. Obstetrics &amp; Gynecology1979;53:81‐7. ">Richter 1979</a>; <a href="./references#CD006169-bbs2-0026" title="SpearingG . Alcohol, indomethacin and salbutamol. A comparative trial of their use in preterm labour. Obstetrics &amp; Gynecology1979;53:171‐4. ">Spearing 1979</a>; <a href="./references#CD006169-bbs2-0027" title="WischnikA , HettenbachA , SchmidtR , ZiegerW , HugG , MelchertF . The effect of magnesium sulfate on volume balance in tocolysis with the beta mimetic agent fenoterol. Gynakologische Rundschau1989;29 Suppl 2:188‐91. ">Wischnik 1989</a>). In three studies the intervention was not relevant to the review; either the women did not receive a combination of tocolytic drugs (<a href="./references#CD006169-bbs2-0012" title="BedoyaJM . Use of orciprenaline in the treatment of threatened premature labour. Proceedings of International Symposium on the Treatment of Fetal Risks; 1972; Baden, Austria. 1972:27‐9. ">Bedoya 1972</a>; <a href="./references#CD006169-bbs2-0014" title="DunlopPDM , CrowleyPA , LamontRF , HawkinsDF . Preterm ruptured membranes, no contractions. Journal of Obstetrics and Gynaecology1986;7:92‐6. ">Dunlop 1986</a>; <a href="./references#CD006169-bbs2-0021" title="MoralesCV . Utility of tocolytic therapy for maintenance tocolysis in the management of threatened preterm delivery (UTM/2012). ClinicalTrials.gov (accessed 21 May 2013)2013. ">Morales 2013</a> ) or women in both arms received the same drugs in different sequences (<a href="./references#CD006169-bbs2-0020" title="KawagoeY , SameshimaH , IkenoueT , YasuhiI , KawarabayashiT . Magnesium sulfate as a second‐line tocolytic agent for preterm labor: a randomized controlled trial in Kyushu Island. Journal of Pregnancy2011;2011:965060. ">Kawagoe 2011</a>). Finally, in the study by <a href="./references#CD006169-bbs2-0015" title="HerzogS , CunzeT , MartinM , OsmersR , GleiterC , KuhnW . Pulsatile vs continuous parenteral tocolysis: comparison of side effects. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1999;85:199‐204. HerzogS , CunzeT , OsmersR , KuhnW . Comparative study of maternal side effects of various forms of intravenous therapy with fenoterol in premature labor. Gynakologisch Geburtshilfliche Rundschau1995;35(1):73‐9. ">Herzog 1999</a>, women were randomised to receive the same combination of tocolytic drugs but the way drugs were administered varied. </p> </section> </section> <section id="CD006169-sec-0081"> <h3 class="title">Risk of bias in included studies</h3> <p>Assessment of the methodological quality of the included studies was based on risk of bias in relation to selection bias (method of randomisation and allocation concealment), performance bias, detection bias, attrition bias (loss of participants from the analyses) and reporting bias. A summary of 'Risk of bias' assessments for each study, and for included trials overall, are set out in <a href="#CD006169-fig-0002">Figure 2</a> and <a href="#CD006169-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD006169-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006169-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD006169-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006169-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD006169-sec-0082"> <h4 class="title">Allocation</h4> <section id="CD006169-sec-0083"> <h5 class="title">Generation of the randomisation sequence</h5> <p>Five studies described methods for generating the randomisation sequence, which we judged were at low risk of bias; <a href="./references#CD006169-bbs2-0001" title="AllyK , NicolasA , ThoumsinH , LambotteR . Magnesium gluconate and intravenous tocolysis with ritodrine. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1992;21:370‐4. ">Ally 1992</a>; <a href="./references#CD006169-bbs2-0004" title="FergusonJE , HensleighPA , KredensterD . Adjunctive use of magnesium sulfate with ritodrine for preterm labor tocolysis. American Journal of Obstetrics and Gynecology1984;148(2):166‐71. FergusonJE , HolbrookH , StevensonDK , HensleighPA , KredentserD . Adjunctive magnesium sulphate infusion does not alter metabolic changes associated with ritodrine tocolysis. American Journal of Obstetrics and Gynecology1987;156:103‐7. ">Ferguson 1984</a>; <a href="./references#CD006169-bbs2-0007" title="HatjisCG , SwainM , NelsonLH , MeisPJ , ErnestJM . Efficacy of combined administration of magnesium sulfate and ritodrine in the treatment of premature labor. Obstetrics and Gynecology1987;69:317‐22. ">Hatjis 1987</a>; and <a href="./references#CD006169-bbs2-0008" title="LauterbachR , RytlewskiK , PawlikD , HurkalaJ , WojtowiczA , BreborowiczG , et al. Effect of Pentoxifylline, administered in preterm labour, on the foetal‐placental circulation and neonatal outcome: a randomized, prospective pilot study. Basic and Clinical Pharmacology and Toxicology2012;110(4):342‐6. ">Lauterbach 2012</a> described using random number tables or pre‐prepared random lists, while <a href="./references#CD006169-bbs2-0002" title="ArikanI , BarutA , HarmaM , HarmaIM . Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor. Gynecologic and Obstetric Investigation2011;72(4):269‐73. ">Arikan 2011</a> reported using a computerised random‐number generator. In the remaining studies, the method for determining the randomisation sequence was either not clear, or not mentioned at all (<a href="./references#CD006169-bbs2-0003" title="CastilloJM , AlonsoJ , Hernandez‐GarciaJM , SanchoB , MartinezV . Study of biochemical and biophysical modifications produced on pregnant women treated in threatened of premature labor with ritodrine and indometacine. 12th World Congress of Gynecology and Obstetrics; 1988 Oct 23‐28; Rio de Janeiro, Brazil. 1988:20. ">Castillo 1988</a>; <a href="./references#CD006169-bbs2-0005" title="FrancioliM , DeMeuronA . Usefulness of the addition of aspartate magnesium hydrochloride via intravenous route to beta mimetics in the treatment of threatened preterm labor. Revue Medicale de la Suisse Romande1988;108:283‐9. ">Francioli 1988</a>; <a href="./references#CD006169-bbs2-0006" title="GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. European Journal of Obstetrics and Gynecology and Reproductive Biology1978;8:123‐8. GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. Proceedings of the 6th European Congress of Perinatal Medicine, August 29th‐September 1st. Vienna, Austria, 1978. GamissansO , CararachV , SerraJ . The role of prostaglandin‐inhibitors, beta‐adrenergic drugs and glucocorticoids in the management of threatened preterm labor. Beta‐mimetic Drugs in Obstetrics and Perinatology. 3rd Symposium on Beta‐mimetic Drugs, Aagen, November 1980. Thieme‐Stratton Inc, 1982:71‐84. ">Gamissans 1982</a>; <a href="./references#CD006169-bbs2-0009" title="Rios‐AnezR , Santos‐LuqueM , NogueraME . Use of an antagonist of the prostaglandins associated to a b‐sympathomimetic agent in the treatment of pre‐term labour [abstract]. Journal of Perinatal Medicine2001;29 Suppl 1(Pt 1):165. ">Rios‐Anez 2001</a>; <a href="./references#CD006169-bbs2-0010" title="RossMG , NicollsE , StubblefieldPG , KitzmillerJL . Intravenous terbutaline and simultaneous beta‐blockade for advanced premature labor. American Journal of Obstetrics and Gynecology1983;147:897‐902. ">Ross 1983</a>; <a href="./references#CD006169-bbs2-0011" title="SchaufB , BeckerS , AbeleH , KleverT , WallwienerD , AydenizB . Effect of magnesium on red blood cell deformability in pregnancy. Hypertension in Pregnancy2005;24(1):17‐27. ">Schauf 2005</a>). </p> </section> <section id="CD006169-sec-0084"> <h5 class="title">Allocation concealment</h5> <p>In eight of the studies, the method for concealing group allocation at the point of randomisation was not clear (<a href="./references#CD006169-bbs2-0001" title="AllyK , NicolasA , ThoumsinH , LambotteR . Magnesium gluconate and intravenous tocolysis with ritodrine. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1992;21:370‐4. ">Ally 1992</a>; <a href="./references#CD006169-bbs2-0002" title="ArikanI , BarutA , HarmaM , HarmaIM . Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor. Gynecologic and Obstetric Investigation2011;72(4):269‐73. ">Arikan 2011</a>; <a href="./references#CD006169-bbs2-0003" title="CastilloJM , AlonsoJ , Hernandez‐GarciaJM , SanchoB , MartinezV . Study of biochemical and biophysical modifications produced on pregnant women treated in threatened of premature labor with ritodrine and indometacine. 12th World Congress of Gynecology and Obstetrics; 1988 Oct 23‐28; Rio de Janeiro, Brazil. 1988:20. ">Castillo 1988</a>; <a href="./references#CD006169-bbs2-0005" title="FrancioliM , DeMeuronA . Usefulness of the addition of aspartate magnesium hydrochloride via intravenous route to beta mimetics in the treatment of threatened preterm labor. Revue Medicale de la Suisse Romande1988;108:283‐9. ">Francioli 1988</a>; <a href="./references#CD006169-bbs2-0008" title="LauterbachR , RytlewskiK , PawlikD , HurkalaJ , WojtowiczA , BreborowiczG , et al. Effect of Pentoxifylline, administered in preterm labour, on the foetal‐placental circulation and neonatal outcome: a randomized, prospective pilot study. Basic and Clinical Pharmacology and Toxicology2012;110(4):342‐6. ">Lauterbach 2012</a>; <a href="./references#CD006169-bbs2-0009" title="Rios‐AnezR , Santos‐LuqueM , NogueraME . Use of an antagonist of the prostaglandins associated to a b‐sympathomimetic agent in the treatment of pre‐term labour [abstract]. Journal of Perinatal Medicine2001;29 Suppl 1(Pt 1):165. ">Rios‐Anez 2001</a>; <a href="./references#CD006169-bbs2-0010" title="RossMG , NicollsE , StubblefieldPG , KitzmillerJL . Intravenous terbutaline and simultaneous beta‐blockade for advanced premature labor. American Journal of Obstetrics and Gynecology1983;147:897‐902. ">Ross 1983</a>; <a href="./references#CD006169-bbs2-0011" title="SchaufB , BeckerS , AbeleH , KleverT , WallwienerD , AydenizB . Effect of magnesium on red blood cell deformability in pregnancy. Hypertension in Pregnancy2005;24(1):17‐27. ">Schauf 2005</a>). <a href="./references#CD006169-bbs2-0006" title="GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. European Journal of Obstetrics and Gynecology and Reproductive Biology1978;8:123‐8. GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. Proceedings of the 6th European Congress of Perinatal Medicine, August 29th‐September 1st. Vienna, Austria, 1978. GamissansO , CararachV , SerraJ . The role of prostaglandin‐inhibitors, beta‐adrenergic drugs and glucocorticoids in the management of threatened preterm labor. Beta‐mimetic Drugs in Obstetrics and Perinatology. 3rd Symposium on Beta‐mimetic Drugs, Aagen, November 1980. Thieme‐Stratton Inc, 1982:71‐84. ">Gamissans 1982</a> described a double‐blind design and <a href="./references#CD006169-bbs2-0004" title="FergusonJE , HensleighPA , KredensterD . Adjunctive use of magnesium sulfate with ritodrine for preterm labor tocolysis. American Journal of Obstetrics and Gynecology1984;148(2):166‐71. FergusonJE , HolbrookH , StevensonDK , HensleighPA , KredentserD . Adjunctive magnesium sulphate infusion does not alter metabolic changes associated with ritodrine tocolysis. American Journal of Obstetrics and Gynecology1987;156:103‐7. ">Ferguson 1984</a> and <a href="./references#CD006169-bbs2-0007" title="HatjisCG , SwainM , NelsonLH , MeisPJ , ErnestJM . Efficacy of combined administration of magnesium sulfate and ritodrine in the treatment of premature labor. Obstetrics and Gynecology1987;69:317‐22. ">Hatjis 1987</a> concealed allocations in sealed envelopes. </p> </section> </section> <section id="CD006169-sec-0085"> <h4 class="title">Blinding</h4> <p>Four of the studies were placebo‐controlled and were assessed as being at low risk of bias for blinding (<a href="./references#CD006169-bbs2-0004" title="FergusonJE , HensleighPA , KredensterD . Adjunctive use of magnesium sulfate with ritodrine for preterm labor tocolysis. American Journal of Obstetrics and Gynecology1984;148(2):166‐71. FergusonJE , HolbrookH , StevensonDK , HensleighPA , KredentserD . Adjunctive magnesium sulphate infusion does not alter metabolic changes associated with ritodrine tocolysis. American Journal of Obstetrics and Gynecology1987;156:103‐7. ">Ferguson 1984</a>; <a href="./references#CD006169-bbs2-0006" title="GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. European Journal of Obstetrics and Gynecology and Reproductive Biology1978;8:123‐8. GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. Proceedings of the 6th European Congress of Perinatal Medicine, August 29th‐September 1st. Vienna, Austria, 1978. GamissansO , CararachV , SerraJ . The role of prostaglandin‐inhibitors, beta‐adrenergic drugs and glucocorticoids in the management of threatened preterm labor. Beta‐mimetic Drugs in Obstetrics and Perinatology. 3rd Symposium on Beta‐mimetic Drugs, Aagen, November 1980. Thieme‐Stratton Inc, 1982:71‐84. ">Gamissans 1982</a>; <a href="./references#CD006169-bbs2-0010" title="RossMG , NicollsE , StubblefieldPG , KitzmillerJL . Intravenous terbutaline and simultaneous beta‐blockade for advanced premature labor. American Journal of Obstetrics and Gynecology1983;147:897‐902. ">Ross 1983</a>; <a href="./references#CD006169-bbs2-0011" title="SchaufB , BeckerS , AbeleH , KleverT , WallwienerD , AydenizB . Effect of magnesium on red blood cell deformability in pregnancy. Hypertension in Pregnancy2005;24(1):17‐27. ">Schauf 2005</a>). In two of these studies, outcome assessors were also blinded (<a href="./references#CD006169-bbs2-0006" title="GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. European Journal of Obstetrics and Gynecology and Reproductive Biology1978;8:123‐8. GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. Proceedings of the 6th European Congress of Perinatal Medicine, August 29th‐September 1st. Vienna, Austria, 1978. GamissansO , CararachV , SerraJ . The role of prostaglandin‐inhibitors, beta‐adrenergic drugs and glucocorticoids in the management of threatened preterm labor. Beta‐mimetic Drugs in Obstetrics and Perinatology. 3rd Symposium on Beta‐mimetic Drugs, Aagen, November 1980. Thieme‐Stratton Inc, 1982:71‐84. ">Gamissans 1982</a>; <a href="./references#CD006169-bbs2-0011" title="SchaufB , BeckerS , AbeleH , KleverT , WallwienerD , AydenizB . Effect of magnesium on red blood cell deformability in pregnancy. Hypertension in Pregnancy2005;24(1):17‐27. ">Schauf 2005</a>), while this was not mentioned in <a href="./references#CD006169-bbs2-0004" title="FergusonJE , HensleighPA , KredensterD . Adjunctive use of magnesium sulfate with ritodrine for preterm labor tocolysis. American Journal of Obstetrics and Gynecology1984;148(2):166‐71. FergusonJE , HolbrookH , StevensonDK , HensleighPA , KredentserD . Adjunctive magnesium sulphate infusion does not alter metabolic changes associated with ritodrine tocolysis. American Journal of Obstetrics and Gynecology1987;156:103‐7. ">Ferguson 1984</a> or <a href="./references#CD006169-bbs2-0010" title="RossMG , NicollsE , StubblefieldPG , KitzmillerJL . Intravenous terbutaline and simultaneous beta‐blockade for advanced premature labor. American Journal of Obstetrics and Gynecology1983;147:897‐902. ">Ross 1983</a>. The remaining studies either did not attempt, or did not mention blinding. As the regimens in different arms of the trials were different, it is likely that staff providing care and evaluating outcomes would be aware of treatment allocation, and these studies have been assessed as high risk of bias due to lack of blinding (<a href="./references#CD006169-bbs2-0001" title="AllyK , NicolasA , ThoumsinH , LambotteR . Magnesium gluconate and intravenous tocolysis with ritodrine. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1992;21:370‐4. ">Ally 1992</a>; <a href="./references#CD006169-bbs2-0002" title="ArikanI , BarutA , HarmaM , HarmaIM . Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor. Gynecologic and Obstetric Investigation2011;72(4):269‐73. ">Arikan 2011</a>; <a href="./references#CD006169-bbs2-0003" title="CastilloJM , AlonsoJ , Hernandez‐GarciaJM , SanchoB , MartinezV . Study of biochemical and biophysical modifications produced on pregnant women treated in threatened of premature labor with ritodrine and indometacine. 12th World Congress of Gynecology and Obstetrics; 1988 Oct 23‐28; Rio de Janeiro, Brazil. 1988:20. ">Castillo 1988</a>; <a href="./references#CD006169-bbs2-0005" title="FrancioliM , DeMeuronA . Usefulness of the addition of aspartate magnesium hydrochloride via intravenous route to beta mimetics in the treatment of threatened preterm labor. Revue Medicale de la Suisse Romande1988;108:283‐9. ">Francioli 1988</a>; <a href="./references#CD006169-bbs2-0007" title="HatjisCG , SwainM , NelsonLH , MeisPJ , ErnestJM . Efficacy of combined administration of magnesium sulfate and ritodrine in the treatment of premature labor. Obstetrics and Gynecology1987;69:317‐22. ">Hatjis 1987</a>; <a href="./references#CD006169-bbs2-0008" title="LauterbachR , RytlewskiK , PawlikD , HurkalaJ , WojtowiczA , BreborowiczG , et al. Effect of Pentoxifylline, administered in preterm labour, on the foetal‐placental circulation and neonatal outcome: a randomized, prospective pilot study. Basic and Clinical Pharmacology and Toxicology2012;110(4):342‐6. ">Lauterbach 2012</a>; <a href="./references#CD006169-bbs2-0009" title="Rios‐AnezR , Santos‐LuqueM , NogueraME . Use of an antagonist of the prostaglandins associated to a b‐sympathomimetic agent in the treatment of pre‐term labour [abstract]. Journal of Perinatal Medicine2001;29 Suppl 1(Pt 1):165. ">Rios‐Anez 2001</a>). </p> </section> <section id="CD006169-sec-0086"> <h4 class="title">Incomplete outcome data</h4> <p>There was no serious sample attrition in the trials by <a href="./references#CD006169-bbs2-0001" title="AllyK , NicolasA , ThoumsinH , LambotteR . Magnesium gluconate and intravenous tocolysis with ritodrine. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1992;21:370‐4. ">Ally 1992</a>, <a href="./references#CD006169-bbs2-0002" title="ArikanI , BarutA , HarmaM , HarmaIM . Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor. Gynecologic and Obstetric Investigation2011;72(4):269‐73. ">Arikan 2011</a>, <a href="./references#CD006169-bbs2-0005" title="FrancioliM , DeMeuronA . Usefulness of the addition of aspartate magnesium hydrochloride via intravenous route to beta mimetics in the treatment of threatened preterm labor. Revue Medicale de la Suisse Romande1988;108:283‐9. ">Francioli 1988</a> and <a href="./references#CD006169-bbs2-0006" title="GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. European Journal of Obstetrics and Gynecology and Reproductive Biology1978;8:123‐8. GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. Proceedings of the 6th European Congress of Perinatal Medicine, August 29th‐September 1st. Vienna, Austria, 1978. GamissansO , CararachV , SerraJ . The role of prostaglandin‐inhibitors, beta‐adrenergic drugs and glucocorticoids in the management of threatened preterm labor. Beta‐mimetic Drugs in Obstetrics and Perinatology. 3rd Symposium on Beta‐mimetic Drugs, Aagen, November 1980. Thieme‐Stratton Inc, 1982:71‐84. ">Gamissans 1982</a>, and loss to follow‐up was not clear for <a href="./references#CD006169-bbs2-0003" title="CastilloJM , AlonsoJ , Hernandez‐GarciaJM , SanchoB , MartinezV . Study of biochemical and biophysical modifications produced on pregnant women treated in threatened of premature labor with ritodrine and indometacine. 12th World Congress of Gynecology and Obstetrics; 1988 Oct 23‐28; Rio de Janeiro, Brazil. 1988:20. ">Castillo 1988</a>, <a href="./references#CD006169-bbs2-0009" title="Rios‐AnezR , Santos‐LuqueM , NogueraME . Use of an antagonist of the prostaglandins associated to a b‐sympathomimetic agent in the treatment of pre‐term labour [abstract]. Journal of Perinatal Medicine2001;29 Suppl 1(Pt 1):165. ">Rios‐Anez 2001</a>, <a href="./references#CD006169-bbs2-0010" title="RossMG , NicollsE , StubblefieldPG , KitzmillerJL . Intravenous terbutaline and simultaneous beta‐blockade for advanced premature labor. American Journal of Obstetrics and Gynecology1983;147:897‐902. ">Ross 1983</a> and <a href="./references#CD006169-bbs2-0011" title="SchaufB , BeckerS , AbeleH , KleverT , WallwienerD , AydenizB . Effect of magnesium on red blood cell deformability in pregnancy. Hypertension in Pregnancy2005;24(1):17‐27. ">Schauf 2005</a>. In three trials, sample attrition was a serious source of bias. In these studies a significant proportion of the women were excluded from the study after randomisation or were lost to follow‐up for reasons that may have related to treatment, and this may have affected outcomes (e.g. delivered early or withdrew due to side effects) (<a href="./references#CD006169-bbs2-0004" title="FergusonJE , HensleighPA , KredensterD . Adjunctive use of magnesium sulfate with ritodrine for preterm labor tocolysis. American Journal of Obstetrics and Gynecology1984;148(2):166‐71. FergusonJE , HolbrookH , StevensonDK , HensleighPA , KredentserD . Adjunctive magnesium sulphate infusion does not alter metabolic changes associated with ritodrine tocolysis. American Journal of Obstetrics and Gynecology1987;156:103‐7. ">Ferguson 1984</a>; <a href="./references#CD006169-bbs2-0007" title="HatjisCG , SwainM , NelsonLH , MeisPJ , ErnestJM . Efficacy of combined administration of magnesium sulfate and ritodrine in the treatment of premature labor. Obstetrics and Gynecology1987;69:317‐22. ">Hatjis 1987</a>; <a href="./references#CD006169-bbs2-0008" title="LauterbachR , RytlewskiK , PawlikD , HurkalaJ , WojtowiczA , BreborowiczG , et al. Effect of Pentoxifylline, administered in preterm labour, on the foetal‐placental circulation and neonatal outcome: a randomized, prospective pilot study. Basic and Clinical Pharmacology and Toxicology2012;110(4):342‐6. ">Lauterbach 2012</a>). </p> </section> <section id="CD006169-sec-0087"> <h4 class="title">Selective reporting</h4> <p>Although the assumption that if something was not reported it was not done could be true for most of the trials that are currently published, the inadequate reporting for most of the trials included in this review could be also related to the period during which the majority of them were published. The lack of information for those published during the 1980s made methodological quality evaluation difficult (<a href="./references#CD006169-bbs2-0003" title="CastilloJM , AlonsoJ , Hernandez‐GarciaJM , SanchoB , MartinezV . Study of biochemical and biophysical modifications produced on pregnant women treated in threatened of premature labor with ritodrine and indometacine. 12th World Congress of Gynecology and Obstetrics; 1988 Oct 23‐28; Rio de Janeiro, Brazil. 1988:20. ">Castillo 1988</a>; <a href="./references#CD006169-bbs2-0004" title="FergusonJE , HensleighPA , KredensterD . Adjunctive use of magnesium sulfate with ritodrine for preterm labor tocolysis. American Journal of Obstetrics and Gynecology1984;148(2):166‐71. FergusonJE , HolbrookH , StevensonDK , HensleighPA , KredentserD . Adjunctive magnesium sulphate infusion does not alter metabolic changes associated with ritodrine tocolysis. American Journal of Obstetrics and Gynecology1987;156:103‐7. ">Ferguson 1984</a>, <a href="./references#CD006169-bbs2-0005" title="FrancioliM , DeMeuronA . Usefulness of the addition of aspartate magnesium hydrochloride via intravenous route to beta mimetics in the treatment of threatened preterm labor. Revue Medicale de la Suisse Romande1988;108:283‐9. ">Francioli 1988</a>; <a href="./references#CD006169-bbs2-0006" title="GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. European Journal of Obstetrics and Gynecology and Reproductive Biology1978;8:123‐8. GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. Proceedings of the 6th European Congress of Perinatal Medicine, August 29th‐September 1st. Vienna, Austria, 1978. GamissansO , CararachV , SerraJ . The role of prostaglandin‐inhibitors, beta‐adrenergic drugs and glucocorticoids in the management of threatened preterm labor. Beta‐mimetic Drugs in Obstetrics and Perinatology. 3rd Symposium on Beta‐mimetic Drugs, Aagen, November 1980. Thieme‐Stratton Inc, 1982:71‐84. ">Gamissans 1982</a>; <a href="./references#CD006169-bbs2-0007" title="HatjisCG , SwainM , NelsonLH , MeisPJ , ErnestJM . Efficacy of combined administration of magnesium sulfate and ritodrine in the treatment of premature labor. Obstetrics and Gynecology1987;69:317‐22. ">Hatjis 1987</a>; <a href="./references#CD006169-bbs2-0010" title="RossMG , NicollsE , StubblefieldPG , KitzmillerJL . Intravenous terbutaline and simultaneous beta‐blockade for advanced premature labor. American Journal of Obstetrics and Gynecology1983;147:897‐902. ">Ross 1983</a>). In addition, two studies were assessed using translated notes (<a href="./references#CD006169-bbs2-0001" title="AllyK , NicolasA , ThoumsinH , LambotteR . Magnesium gluconate and intravenous tocolysis with ritodrine. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1992;21:370‐4. ">Ally 1992</a>; <a href="./references#CD006169-bbs2-0005" title="FrancioliM , DeMeuronA . Usefulness of the addition of aspartate magnesium hydrochloride via intravenous route to beta mimetics in the treatment of threatened preterm labor. Revue Medicale de la Suisse Romande1988;108:283‐9. ">Francioli 1988</a>) and, again, this made assessment of selective reporting more difficult. </p> </section> <section id="CD006169-sec-0088"> <h4 class="title">Other potential sources of bias</h4> <p>Most studies described the characteristics of women in each of the study groups, and there was no clear evidence of baseline imbalance. The gestational age was slightly different between groups in the <a href="./references#CD006169-bbs2-0001" title="AllyK , NicolasA , ThoumsinH , LambotteR . Magnesium gluconate and intravenous tocolysis with ritodrine. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1992;21:370‐4. ">Ally 1992</a> trial, and in the <a href="./references#CD006169-bbs2-0004" title="FergusonJE , HensleighPA , KredensterD . Adjunctive use of magnesium sulfate with ritodrine for preterm labor tocolysis. American Journal of Obstetrics and Gynecology1984;148(2):166‐71. FergusonJE , HolbrookH , StevensonDK , HensleighPA , KredentserD . Adjunctive magnesium sulphate infusion does not alter metabolic changes associated with ritodrine tocolysis. American Journal of Obstetrics and Gynecology1987;156:103‐7. ">Ferguson 1984</a> trial, recruitment was stopped early due to the high incidence of side effects, and this may have introduced bias. </p> </section> </section> <section id="CD006169-sec-0089"> <h3 class="title" id="CD006169-sec-0089">Effects of interventions</h3> <p>This systematic review included 11 studies with a total of 895 women. Data from nine randomised controlled trials with a total of 776 women reported outcome data relevant to this review. </p> <p>The sample sizes of all the trials that fulfilled the inclusion criteria were small, most comparisons used data from single studies only and none of them had sufficient clinical power to identify differences between groups for many outcomes. The biggest trial included 208 women and was further subgrouped by state of membranes to deal with clinical heterogeneity (<a href="./references#CD006169-bbs2-0006" title="GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. European Journal of Obstetrics and Gynecology and Reproductive Biology1978;8:123‐8. GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. Proceedings of the 6th European Congress of Perinatal Medicine, August 29th‐September 1st. Vienna, Austria, 1978. GamissansO , CararachV , SerraJ . The role of prostaglandin‐inhibitors, beta‐adrenergic drugs and glucocorticoids in the management of threatened preterm labor. Beta‐mimetic Drugs in Obstetrics and Perinatology. 3rd Symposium on Beta‐mimetic Drugs, Aagen, November 1980. Thieme‐Stratton Inc, 1982:71‐84. ">Gamissans 1982</a>). </p> <p>It was not feasible to compare all combinations together versus single drugs, as the mechanisms of action among different drug families are not the same and combining data in meta‐analysis might have led to heterogeneous and spurious results. Therefore, we examined different combinations of drugs separately. For most of the comparisons and outcomes analysed, only one or few trials reported findings. </p> <section id="CD006169-sec-0090"> <h4 class="title">Comparison 1: IV ritodrine plus IV or oral magnesium (gluconate or sulphate) versus IV ritodrine alone </h4> <p>Three trials compared IV ritodrine plus IV or oral magnesium (gluconate or sulphate) versus IV ritodrine alone. </p> <section id="CD006169-sec-0091"> <h5 class="title">Primary outcomes</h5> <p>Only one trial, including 41 women, evaluated differences in 'adverse drug reactions', showing a higher incidence in the combination group (risk ratio (RR) 7.79, 95% confidence interval (CI) 1.11 to 54.80) (<a href="./references#CD006169-bbs2-0004" title="FergusonJE , HensleighPA , KredensterD . Adjunctive use of magnesium sulfate with ritodrine for preterm labor tocolysis. American Journal of Obstetrics and Gynecology1984;148(2):166‐71. FergusonJE , HolbrookH , StevensonDK , HensleighPA , KredentserD . Adjunctive magnesium sulphate infusion does not alter metabolic changes associated with ritodrine tocolysis. American Journal of Obstetrics and Gynecology1987;156:103‐7. ">Ferguson 1984</a>) (<a href="./references#CD006169-fig-0004" title="">Analysis 1.1</a>). </p> <p>'Discontinuation of therapy' was reported in two trials (<a href="./references#CD006169-bbs2-0001" title="AllyK , NicolasA , ThoumsinH , LambotteR . Magnesium gluconate and intravenous tocolysis with ritodrine. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1992;21:370‐4. ">Ally 1992</a>; <a href="./references#CD006169-bbs2-0004" title="FergusonJE , HensleighPA , KredensterD . Adjunctive use of magnesium sulfate with ritodrine for preterm labor tocolysis. American Journal of Obstetrics and Gynecology1984;148(2):166‐71. FergusonJE , HolbrookH , StevensonDK , HensleighPA , KredentserD . Adjunctive magnesium sulphate infusion does not alter metabolic changes associated with ritodrine tocolysis. American Journal of Obstetrics and Gynecology1987;156:103‐7. ">Ferguson 1984</a>); we have not pooled results due to the high heterogeneity observed between the included trials (I² = 83%); one trial reported increased side effects in the group receiving ritodrine alone (RR 7.79, 95% CI 1.11 to 54.80, 41 women); in the other trial there were no clear differences between groups (RR 0.23, 95% CI 0.03 to 1.97, 107 women), (<a href="./references#CD006169-fig-0005" title="">Analysis 1.2</a>). </p> <p>None of the studies included in this comparison reported on our other primary outcomes.</p> </section> <section id="CD006169-sec-0092"> <h5 class="title">Secondary outcomes</h5> <p>Only one trial (<a href="./references#CD006169-bbs2-0007" title="HatjisCG , SwainM , NelsonLH , MeisPJ , ErnestJM . Efficacy of combined administration of magnesium sulfate and ritodrine in the treatment of premature labor. Obstetrics and Gynecology1987;69:317‐22. ">Hatjis 1987</a>), including 64 women, reported the outcome 'birth before seven days after trial entry'; the difference between groups did not reach statistical significance (RR 0.62, 95% CI 0.38 to 1.01), (<a href="./references#CD006169-fig-0006" title="">Analysis 1.3</a>). One trial of 107 women (<a href="./references#CD006169-bbs2-0001" title="AllyK , NicolasA , ThoumsinH , LambotteR . Magnesium gluconate and intravenous tocolysis with ritodrine. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1992;21:370‐4. ">Ally 1992</a>) assessed birthweight, showing no clear difference between treatment groups (mean difference (MD) 77 g, 95% CI ‐87.86 to 241.86) (<a href="./references#CD006169-fig-0007" title="">Analysis 1.4</a>). </p> <p>Other secondary outcomes were not reported.</p> </section> </section> <section id="CD006169-sec-0093"> <h4 class="title">Comparison 2: IV ritodrine plus indomethacin suppositories versus IV ritodrine alone</h4> <p>For the second comparison, only one trial fulfilled the inclusion criteria (<a href="http://archie.cochrane.org/sections/documents/view?document=2671915F82E26AA2000159B37ABF1BE7%26format=REVMAN#STD-Gamissans-1982" target="_blank">Gamissans 1982</a>). The trial involved 208 women, and the results were reported separately according to the state of the membranes (intact versus ruptured), to handle an evident clinical cause of heterogeneity. Due to significant heterogeneity for the results of some outcomes, we are presenting the results separately for women with intact membranes (153 women) or ruptured membranes (55 women) reflecting the approach used in the trial report. </p> <section id="CD006169-sec-0094"> <h5 class="title">Primary outcomes</h5> <p>There was no clear difference between groups for perinatal mortality in women with intact membranes (RR 0.46, 95% CI 0.17 to 1.26), or ruptured membranes (RR 0.96, 95% CI 0.15 to 6.37) (<a href="http://archie.cochrane.org/sections/documents/view?document=2671915F82E26AA2000159B37ABF1BE7%26format=REVMAN#CMP-002.01" target="_blank">Analysis 2.1</a>). </p> <p>Data on respiratory distress syndrome (RDS) were reported for the women with intact amniotic membranes; there were very few events and no strong evidence of difference between groups (RR 0.51, 95% CI 0.05 to 5.47) (<a href="./references#CD006169-fig-0009" title="">Analysis 2.2</a>). </p> <p>For maternal adverse drug reactions there was no clear difference between groups receiving the combined therapy versus ritodrine alone in either the intact or ruptured membranes groups (RR 1.11, 95% CI 0.67 to 1.87; RR 0.77, 95% CI 0.36 to 1.66, respectively) (<a href="./references#CD006169-fig-0010" title="">Analysis 2.3</a>). </p> <p>Other primary outcomes were not reported.</p> </section> <section id="CD006169-sec-0095"> <h5 class="title">Secondary outcomes</h5> <p>Results showed a statistically significant difference in the number of women giving birth before 37 weeks of gestation and recurrence of labour favouring the combination group in those women with intact membranes (RR 0.70, 95% CI 0.50 to 0.97; RR 0.59, 95% CI 0.36 to 0.99, respectively) (<a href="./references#CD006169-fig-0011" title="">Analysis 2.4</a>; <a href="./references#CD006169-fig-0012" title="">Analysis 2.5</a>). </p> <p>For women with ruptured membranes the evidence did not demonstrate a difference between groups for birth before 37 weeks (RR 0.92, 95% CI 0.70 to 1.22) (<a href="./references#CD006169-fig-0011" title="">Analysis 2.4</a>), and frequency of labour recurrence was very similar in the two treatment groups (RR 1.02, 95% CI 0.68 to 1.52) (<a href="./references#CD006169-fig-0012" title="">Analysis 2.5</a>). </p> <p>No differences were found for infant Apgar score less than seven at five minutes irrespective of membrane status (intact: RR 1.01, 95% CI 0.31 to 3.36; ruptured: RR 1.29, 95% CI 0.32 to 5.22) (<a href="./references#CD006169-fig-0013" title="">Analysis 2.6</a>). </p> <p>Other outcomes were not reported.</p> </section> </section> <section id="CD006169-sec-0096"> <h4 class="title">Comparison 3: IV ritodrine plus vaginal progesterone versus IV ritodrine alone</h4> <p>One study with data for 83 women is included in this comparison (<a href="./references#CD006169-bbs2-0002" title="ArikanI , BarutA , HarmaM , HarmaIM . Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor. Gynecologic and Obstetric Investigation2011;72(4):269‐73. ">Arikan 2011</a>). The study did not have sufficient statistical power to identify differences between groups for most of the outcomes reported. </p> <section id="CD006169-sec-0097"> <h5 class="title">Primary outcomes</h5> <p>There was only one infant death, no significant differences between groups, and very wide 95% CIs around the effect estimate for this outcome (RR 0.31, 95% CI 0.01 to 7.41) (<a href="./references#CD006169-fig-0014" title="">Analysis 3.1</a>). </p> <p>Event rates were low for serious morbidity in newborns, and there were no significant differences between groups for infant sepsis (RR 0.93, 95% CI 0.14 to 6.30) (<a href="./references#CD006169-fig-0015" title="">Analysis 3.2</a>), RDS (RR 0.93, 95% CI 0.06 to 14.38) (<a href="./references#CD006169-fig-0016" title="">Analysis 3.3</a>), or for need for mechanical ventilation (RR 1.86, 95% CI 0.18 to 19.73) (<a href="./references#CD006169-fig-0017" title="">Analysis 3.4</a>). There were no estimable data for infant necrotising enterocolitis or intraventricular haemorrhage. </p> </section> <section id="CD006169-sec-0098"> <h5 class="title">Secondary outcomes</h5> <p>There were low event rates for poor infant outcomes at birth and no apparent differences between groups for low infant Apgar score at five minutes (RR 0.23, 95% CI 0.03 to 1.99) (<a href="./references#CD006169-fig-0020" title="">Analysis 3.7</a>), arterial blood pH less than 7.1 (non pre‐specified outcome) (RR 0.47, 95% CI 0.09 to 2.40) (<a href="./references#CD006169-fig-0021" title="">Analysis 3.8</a>), infant admission to neonatal intensive care unit (NICU) (RR 0.93, 95% CI 0.20 to 4.34) (<a href="./references#CD006169-fig-0022" title="">Analysis 3.9</a>), or mean length of NICU stay (days) (MD ‐7.90, 95% CI ‐48.95 to 33.15) (the denominator for this last non‐prespecified outcome was not clear, and in the analysis we have used the number of babies admitted to NICU rather than the whole sample) (<a href="./references#CD006169-fig-0023" title="">Analysis 3.10</a>). </p> <p>Infants whose mothers were randomised to receive the combination of tocolytics were less likely to have a low birthweight (less than 2500 g) (RR 0.41, 95% CI 0.20 to 0.84) (<a href="./references#CD006169-fig-0025" title="">Analysis 3.12</a>), and a higher mean birthweight (MD 398.0 g, 95% CI 86.37 to 709.63) (<a href="./references#CD006169-fig-0024" title="">Analysis 3.11</a>). </p> <p>The period between randomisation and birth (latency) was increased for women in the combined group by a mean of almost 11 days (MD 10.90, 95% CI 3.56 to 18.24) (<a href="./references#CD006169-fig-0027" title="">Analysis 3.14</a>). This finding was reflected in fewer women giving birth before 37 weeks in the combined tocolytic group (RR 0.66, 95% CI 0.45 to 0.97) (<a href="./references#CD006169-fig-0026" title="">Analysis 3.13</a>), and an increase in the mean gestational age at delivery (MD 1.20 weeks, 95% CI 0.08 to 2.32) (<a href="./references#CD006169-fig-0028" title="">Analysis 3.15</a>). </p> <p>There was no significant difference between groups for caesarean section (RR 0.75, 95% CI 0.51 to 1.10) (<a href="./references#CD006169-fig-0029" title="">Analysis 3.16</a>). Other outcomes were not reported. </p> </section> </section> <section id="CD006169-sec-0099"> <h4 class="title">Comparison 4: IV hexoprenaline sulphate plus IV magnesium hydrochloride versus IV hexoprenaline sulphate alone </h4> <p>Only 24 women were recruited in the only trial included in this comparison (<a href="./references#CD006169-bbs2-0005" title="FrancioliM , DeMeuronA . Usefulness of the addition of aspartate magnesium hydrochloride via intravenous route to beta mimetics in the treatment of threatened preterm labor. Revue Medicale de la Suisse Romande1988;108:283‐9. ">Francioli 1988</a>), with no difference observed in the only outcome analysed by the authors: birth before seven days of trial entry (RR 0.85, 95% CI 0.14 to 5.06) (<a href="./references#CD006169-fig-0030" title="">Analysis 4.1</a>). </p> </section> <section id="CD006169-sec-0100"> <h4 class="title">Comparison 5: IV fenoterol plus oral naproxen versus IV fenoterol alone</h4> <p>For the comparison IV fenoterol plus oral naproxen versus IV fenoterol alone, only one trial was included (<a href="./references#CD006169-bbs2-0009" title="Rios‐AnezR , Santos‐LuqueM , NogueraME . Use of an antagonist of the prostaglandins associated to a b‐sympathomimetic agent in the treatment of pre‐term labour [abstract]. Journal of Perinatal Medicine2001;29 Suppl 1(Pt 1):165. ">Rios‐Anez 2001</a>). In this trial only 72 women were recruited and results did not show any difference in the only outcome relevant to the review that was reported: 'birth before 37 weeks of gestation' (RR 0.50, 95% CI 0.23 to 1.09) (<a href="./references#CD006169-fig-0031" title="">Analysis 5.1</a>). </p> </section> <section id="CD006169-sec-0101"> <h4 class="title">Comparison 6: Oral pentoxifylline plus IV magnesium sulphate plus IV fenoterol versus IV magnesium sulphate plus IV fenoterol </h4> <p>One trial examined this comparison (<a href="./references#CD006169-bbs2-0008" title="LauterbachR , RytlewskiK , PawlikD , HurkalaJ , WojtowiczA , BreborowiczG , et al. Effect of Pentoxifylline, administered in preterm labour, on the foetal‐placental circulation and neonatal outcome: a randomized, prospective pilot study. Basic and Clinical Pharmacology and Toxicology2012;110(4):342‐6. ">Lauterbach 2012</a>). One‐hundred and forty‐eight women were randomised; however, there was considerable loss to follow‐up following randomisation. </p> <p>Data for perinatal death and delivery within seven days were available for 125 women. There was no significant difference between groups for perinatal death (RR 0.19, 95% CI 0.02 to 1.55) (<a href="./references#CD006169-fig-0032" title="">Analysis 6.1</a>), or delivery within seven days (RR 0.77, 95% CI 0.29 to 2.03) (<a href="./references#CD006169-fig-0033" title="">Analysis 6.2</a>). </p> <p>Other outcomes were reported in this trial but analyses excluded women who either delivered within the first week of tocolysis, or withdrew from the trial, or changed the place of birth, or were intolerant to pentoxifylline. Of the 148 women randomised, data for pregnancy outcomes and serious infant morbidity were reported for only 96 of the original sample: 39% of the intervention group and 31% of the control group were not included in the analysis of these outcomes. In view of the high risk of bias for such outcomes, we have not, therefore, reported them in this review. </p> </section> <section id="CD006169-sec-0102"> <h4 class="title">Comparison 7: IV terbutaline plus oral metoprolol versus IV terbutaline alone</h4> <p>One trial with data for 17 women is included in this comparison (<a href="./references#CD006169-bbs2-0010" title="RossMG , NicollsE , StubblefieldPG , KitzmillerJL . Intravenous terbutaline and simultaneous beta‐blockade for advanced premature labor. American Journal of Obstetrics and Gynecology1983;147:897‐902. ">Ross 1983</a>). Only two outcomes relevant to the review were reported. There was no clear difference between groups for mean time to delivery and the standard deviations for this outcome suggest considerable variation within groups (MD ‐6.80 days, 95% CI ‐14.92 to 1.32) (<a href="./references#CD006169-fig-0035" title="">Analysis 7.2</a>). No women in either arm of this trial were reported to have oedema (non pre‐specified outcome). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006169-sec-0103" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006169-sec-0103"></div> <p>This systematic review included 11 studies with a total of 895 women. Data from nine randomised controlled trials with a total of 776 women reported outcome data relevant to this review. Overall, seven different combinations of tocolytic drugs were examined with only one or few small trials per comparison, so very few data were pooled in meta‐analysis. While most of the included studies reported some measure of pregnancy prolongation, other outcomes were infrequently reported. </p> <section id="CD006169-sec-0104"> <h3 class="title" id="CD006169-sec-0104">Summary of main results</h3> <p>Three trials examined intravenous (IV) ritodrine plus oral or IV magnesium (sulphate or gluconate) compared with IV ritodrine alone. One study with 41 women reported more adverse drug reactions in the group receiving the combination of tocolytic drugs. Two trials reported discontinuation of therapy due to severe side effects, with one trial reporting increased side effects in the group receiving ritodrine alone, while in the other trial there was no clear difference between groups. Other outcomes were either not reported, or not statistically significant. </p> <p>One trial compared IV ritodrine plus indomethacin suppositories versus IV ritodrine alone. There were no significant differences between groups for perinatal death serious neonatal morbidity. Results for other primary outcomes were not reported.. </p> <p>There were no significant differences between groups receiving IV ritodrine plus vaginal progesterone compared with IV ritodrine alone for most outcomes reported, although the latency period (time from randomisation to delivery) was increased in the group receiving the combination of tocolytics. </p> <p>For other combinations of tocolytic agents, results did not demonstrate differences between groups. </p> </section> <section id="CD006169-sec-0105"> <h3 class="title" id="CD006169-sec-0105">Overall completeness and applicability of evidence</h3> <p>Although the aim of this systematic review was to evaluate combinations of tocolytic agents compared with any other treatment on maternal and neonatal outcomes, we pre‐specified outcomes chosen as the most representative clinical measures of effectiveness and complications. Unfortunately, some of these outcomes, particularly those to which the tocolytic treatment would be most relevant (e.g. 'birth before 48 hours of trial entry' to allow the administration of a complete course of corticosteroids)<i>,</i> were not assessed by any of the included studies. </p> <p>The samples sizes of the individual trials were generally small. Moreover, the analysis of the largest study (which included only 208 women) was stratified into two groups because of a clinical source of heterogeneity (state of membranes). This and the poor quality of reporting in the majority of the included trials made conclusions difficult, and in most cases studies were underpowered to identify differences between groups. Antenatal corticosteroid use has an important effect on neonatal outcomes, however, its use was reported in only five of the included studies. Thus review findings must to be interpreted with considerable caution. </p> <p>The most serious practical limitation of this systematic review is that none of the identified studies (included and excluded) evaluated two of the most commonly used tocolytic agents in high‐resource settings, atosiban and nifedipine, as part of a combination or single tocolytic therapy. Many settings have abandoned the use of betamimetics for tocolysis due to their unfavourable side‐effect profile in comparison with other agents (<a href="./references#CD006169-bbs2-0038" title="FlenadyV , WojcieszekAM , PapatsonisDNM , StockOM , MurrayL , JardineLA , CarbonneB . Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database of Systematic Reviews2014, Issue 6. [DOI: 10.1002/14651858.CD002255.pub2] ">Flenady 2014</a>). These results are therefore not clinically relevant in settings where betamimetics are no longer used. </p> <p>A theoretically effective combination of tocolytics would include agents that act through different mechanisms, affecting contractile proteins in the myometrial cell and also blocking the action of myometrial stimulants. The latter action is only known to be performed by cyclo‐oxygenase (COX) inhibitors (indomethacin) and oxytocin antagonists (atosiban). Therefore, future trials of combinations of tocolytic agents should, where appropriate, include at least one of these two agents, as well as considering the need to evaluate calcium channel blockers in combination regimens. </p> </section> <section id="CD006169-sec-0106"> <h3 class="title" id="CD006169-sec-0106">Quality of the evidence</h3> <p>It was difficult to assess the methodological quality of most of the trials included in the review because of poor reporting. In most of the trials, methods for generating the randomisation sequence and concealing allocation at the point of randomisation were not clear or presented high risk of bias. Only four of the trials reported that blinding had been attempted. Lack of blinding may mean findings are at high risk of bias, as care would have been provided, and many of the outcomes assessed, by staff who would have been aware of what treatment a woman had received. In three trials, sample attrition was a serious source of bias because women were excluded from the study after randomisation or were lost to follow‐up for reasons that may have related to treatment and this may have affected outcomes. </p> </section> <section id="CD006169-sec-0107"> <h3 class="title" id="CD006169-sec-0107">Potential biases in the review process</h3> <p>We are aware that the review process itself is subject to bias, and we took steps to minimise bias. At least two review authors carried out data extraction and assessed risk of bias independently; however, a different review team may not have made identical decisions. </p> </section> <section id="CD006169-sec-0108"> <h3 class="title" id="CD006169-sec-0108">Agreements and disagreements with other studies or reviews</h3> <p>As with previous Cochrane reviews of tocolytic drugs, this review showed that betamimetics are the most commonly studied tocolytic agent. However, one review has demonstrated that (when used alone) calcium channel blockers are preferred to other single tocolytic drugs, particularly betamimetics (mostly ritodrine), due to comparable efficacy and fewer side effects (<a href="./references#CD006169-bbs2-0038" title="FlenadyV , WojcieszekAM , PapatsonisDNM , StockOM , MurrayL , JardineLA , CarbonneB . Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database of Systematic Reviews2014, Issue 6. [DOI: 10.1002/14651858.CD002255.pub2] ">Flenady 2014</a>). Despite this, we found no trial that included calcium channel blockers in a combination tocolytic regimen. A review of the use of COX inhibitors alone (including indomethacin) for treating preterm labour could not recommend COX inhibitor use due to insufficient data (<a href="./references#CD006169-bbs2-0046" title="KingJF , FlenadyV , ColeS , ThorntonS . Cyclo‐oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database of Systematic Reviews2005, Issue 2. [DOI: 10.1002/14651858.CD001992.pub2] ">King 2005</a>). However, in a small number of participants COX inhibitors reduced the proportion of women delivering preterm. The risks associated with magnesium sulphate alone in threatened preterm labour (<a href="./references#CD006169-bbs2-0034" title="CrowtherCA , HillerJE , DoyleLW . Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD001060] ">Crowther 2002</a>) should be carefully considered in tocolytic combination regimens. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006169-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD006169-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/full#CD006169-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006169-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/full#CD006169-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006169-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/full#CD006169-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IV ritodrine plus oral/IV magnesium (gluconate or sulphate) versus IV ritodrine, Outcome 1 Adverse drug reaction." data-id="CD006169-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 IV ritodrine plus oral/IV magnesium (gluconate or sulphate) versus IV ritodrine, Outcome 1 Adverse drug reaction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IV ritodrine plus oral/IV magnesium (gluconate or sulphate) versus IV ritodrine, Outcome 2 Discontinuation of therapy because of maternal side effects." data-id="CD006169-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 IV ritodrine plus oral/IV magnesium (gluconate or sulphate) versus IV ritodrine, Outcome 2 Discontinuation of therapy because of maternal side effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IV ritodrine plus oral/IV magnesium (gluconate or sulphate) versus IV ritodrine, Outcome 3 Birth before 7 days of trial entry." data-id="CD006169-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 IV ritodrine plus oral/IV magnesium (gluconate or sulphate) versus IV ritodrine, Outcome 3 Birth before 7 days of trial entry. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IV ritodrine plus oral/IV magnesium (gluconate or sulphate) versus IV ritodrine, Outcome 4 Birthweight." data-id="CD006169-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 IV ritodrine plus oral/IV magnesium (gluconate or sulphate) versus IV ritodrine, Outcome 4 Birthweight. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 IV ritodrine plus indomethacin suppositories versus IV ritodrine (subgrouped by state of membranes), Outcome 1 Perinatal mortality." data-id="CD006169-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 IV ritodrine plus indomethacin suppositories versus IV ritodrine (subgrouped by state of membranes), Outcome 1 Perinatal mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 IV ritodrine plus indomethacin suppositories versus IV ritodrine (subgrouped by state of membranes), Outcome 2 Respiratory distress syndrome." data-id="CD006169-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 IV ritodrine plus indomethacin suppositories versus IV ritodrine (subgrouped by state of membranes), Outcome 2 Respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 IV ritodrine plus indomethacin suppositories versus IV ritodrine (subgrouped by state of membranes), Outcome 3 Adverse drug reaction." data-id="CD006169-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 IV ritodrine plus indomethacin suppositories versus IV ritodrine (subgrouped by state of membranes), Outcome 3 Adverse drug reaction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 IV ritodrine plus indomethacin suppositories versus IV ritodrine (subgrouped by state of membranes), Outcome 4 Birth before 37 weeks." data-id="CD006169-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 IV ritodrine plus indomethacin suppositories versus IV ritodrine (subgrouped by state of membranes), Outcome 4 Birth before 37 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 IV ritodrine plus indomethacin suppositories versus IV ritodrine (subgrouped by state of membranes), Outcome 5 Recurrence of labour." data-id="CD006169-fig-0012" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 IV ritodrine plus indomethacin suppositories versus IV ritodrine (subgrouped by state of membranes), Outcome 5 Recurrence of labour. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 IV ritodrine plus indomethacin suppositories versus IV ritodrine (subgrouped by state of membranes), Outcome 6 Apgar score &lt; 7 at 5 minutes." data-id="CD006169-fig-0013" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 IV ritodrine plus indomethacin suppositories versus IV ritodrine (subgrouped by state of membranes), Outcome 6 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 1 Infant mortality." data-id="CD006169-fig-0014" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 1 Infant mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 2 Infant sepsis." data-id="CD006169-fig-0015" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 2 Infant sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 3 RDS." data-id="CD006169-fig-0016" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 3 RDS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 4 Use of mechanical ventilation." data-id="CD006169-fig-0017" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 4 Use of mechanical ventilation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 5 Necrotising enterocolitis." data-id="CD006169-fig-0018" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 5 Necrotising enterocolitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 6 Intraventricular haemorrhage." data-id="CD006169-fig-0019" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 6 Intraventricular haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 7 Apgar less than 7 at 5 minutes." data-id="CD006169-fig-0020" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 7 Apgar less than 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 8 (Non pre‐specified) Arterial pH &lt; 7.1." data-id="CD006169-fig-0021" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 8 (Non pre‐specified) Arterial pH &lt; 7.1. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 9 NICU admission." data-id="CD006169-fig-0022" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 9 NICU admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-003-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 10 Mean NICU stay (days)." data-id="CD006169-fig-0023" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 10 Mean NICU stay (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 11 Mean birthweight (g)." data-id="CD006169-fig-0024" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 11 Mean birthweight (g). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-003-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-003-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 12 Low birthweight (&lt; 2500 g)." data-id="CD006169-fig-0025" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 12 Low birthweight (&lt; 2500 g). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-003-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-003-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 13 Delivery before 37 weeks." data-id="CD006169-fig-0026" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.13</div> <div class="figure-caption"> <p>Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 13 Delivery before 37 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-003-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-003-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 14 Latency ‐ days." data-id="CD006169-fig-0027" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.14</div> <div class="figure-caption"> <p>Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 14 Latency ‐ days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-003-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-003-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 15 Mean GA at delivery." data-id="CD006169-fig-0028" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.15</div> <div class="figure-caption"> <p>Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 15 Mean GA at delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-003-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-003-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 16 Caesarean section." data-id="CD006169-fig-0029" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.16</div> <div class="figure-caption"> <p>Comparison 3 IV ritodrine plus vaginal progesterone versus IV ritodrine, Outcome 16 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-003-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 IV hexoprenaline plus IV magnesium sulphate versus IV hexoprenaline, Outcome 1 Birth before 7 days of trial entry." data-id="CD006169-fig-0030" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 IV hexoprenaline plus IV magnesium sulphate versus IV hexoprenaline, Outcome 1 Birth before 7 days of trial entry. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 IV fenoterol plus oral naproxen versus IV fenoterol, Outcome 1 Birth before 37 weeks." data-id="CD006169-fig-0031" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 IV fenoterol plus oral naproxen versus IV fenoterol, Outcome 1 Birth before 37 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral pentoxifylline plus IV magnesium sulphate plus IV fenoterol versus IV magnesium sulphate plus IV fenoterol, Outcome 1 Perinatal death." data-id="CD006169-fig-0032" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Oral pentoxifylline plus IV magnesium sulphate plus IV fenoterol versus IV magnesium sulphate plus IV fenoterol, Outcome 1 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral pentoxifylline plus IV magnesium sulphate plus IV fenoterol versus IV magnesium sulphate plus IV fenoterol, Outcome 2 Delivery with 7 days." data-id="CD006169-fig-0033" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Oral pentoxifylline plus IV magnesium sulphate plus IV fenoterol versus IV magnesium sulphate plus IV fenoterol, Outcome 2 Delivery with 7 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 IV terbutaline plus oral metoprolol versus IV terbutaline, Outcome 1 (Non‐prespecified) Maternal oedema." data-id="CD006169-fig-0034" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 IV terbutaline plus oral metoprolol versus IV terbutaline, Outcome 1 (Non‐prespecified) Maternal oedema. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006169-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/urn:x-wiley:14651858:media:CD006169:CD006169-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_t/tCD006169-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 IV terbutaline plus oral metoprolol versus IV terbutaline, Outcome 2 Mean time to delivery." data-id="CD006169-fig-0035" src="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 IV terbutaline plus oral metoprolol versus IV terbutaline, Outcome 2 Mean time to delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/media/CDSR/CD006169/image_n/nCD006169-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="comparison" data-id="CD006169-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">IV ritodrine plus oral/IV magnesium (gluconate or sulphate) versus IV ritodrine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Adverse drug reaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.79 [1.11, 54.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Discontinuation of therapy because of maternal side effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Birth before 7 days of trial entry <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.38, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Birthweight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>77.0 [‐87.86, 241.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">IV ritodrine plus oral/IV magnesium (gluconate or sulphate) versus IV ritodrine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006169-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">IV ritodrine plus indomethacin suppositories versus IV ritodrine (subgrouped by state of membranes)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Perinatal mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Intact membranes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.17, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Ruptured membranes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.15, 6.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.05, 5.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Intact membranes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.05, 5.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse drug reaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Intact membranes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.67, 1.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Ruptured membranes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.36, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Birth before 37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Intact membranes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.50, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Ruptured membranes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.70, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Recurrence of labour <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Intact membranes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.36, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Ruptured membranes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.68, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Intact membranes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.31, 3.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Ruptured membranes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.32, 5.22]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">IV ritodrine plus indomethacin suppositories versus IV ritodrine (subgrouped by state of membranes)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006169-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">IV ritodrine plus vaginal progesterone versus IV ritodrine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Infant mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.01, 7.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Infant sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.14, 6.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 RDS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.06, 14.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Use of mechanical ventilation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.86 [0.18, 19.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Necrotising enterocolitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Intraventricular haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar less than 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.03, 1.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 (Non pre‐specified) Arterial pH &lt; 7.1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.09, 2.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 NICU admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.20, 4.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Mean NICU stay (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.90 [‐48.95, 33.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Mean birthweight (g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>398.00 [86.37, 709.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Low birthweight (&lt; 2500 g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.20, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Delivery before 37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.45, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Latency ‐ days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.90 [3.56, 18.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Mean GA at delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.08, 2.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.51, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">IV ritodrine plus vaginal progesterone versus IV ritodrine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006169-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">IV hexoprenaline plus IV magnesium sulphate versus IV hexoprenaline</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Birth before 7 days of trial entry <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.14, 5.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">IV hexoprenaline plus IV magnesium sulphate versus IV hexoprenaline</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006169-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">IV fenoterol plus oral naproxen versus IV fenoterol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Birth before 37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.23, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">IV fenoterol plus oral naproxen versus IV fenoterol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006169-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Oral pentoxifylline plus IV magnesium sulphate plus IV fenoterol versus IV magnesium sulphate plus IV fenoterol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.02, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Delivery with 7 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.29, 2.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Oral pentoxifylline plus IV magnesium sulphate plus IV fenoterol versus IV magnesium sulphate plus IV fenoterol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006169-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">IV terbutaline plus oral metoprolol versus IV terbutaline</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 (Non‐prespecified) Maternal oedema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mean time to delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.80 [‐14.92, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">IV terbutaline plus oral metoprolol versus IV terbutaline</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006169.pub2/references#CD006169-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006169.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD006169-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006169-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD006169-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD006169-note-0001">Hrvatski</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006169\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006169\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006169\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006169\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006169\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006169\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006169\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006169\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006169\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006169\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006169\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006169\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006169\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006169\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006169\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006169\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006169\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006169\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=QzbxnhyM&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006169.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006169.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006169.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006169.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006169.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717851793"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006169.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717851796"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006169.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dc203ab919377',t:'MTc0MDcxNzg1Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 